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ABSTRACT 
DOUGLAS K. BREES. Heterogeneous Macromolecular Composition of Renal 
Basement Membranes in Health, Diabetes and Glomerulonephritis. (Under the direction 
of JAMES C. WILLIAMS, JR.) 
Although basement membranes are ubiquitous structures throughout the body, 
basement membranes have distinct compositions that are specific to their location. This 
basement membrane heterogeneity may, in part, reflect functional differences among 
various basement membranes. We examined basement membrane heterogeneity in 
normal, healthy mouse kidneys to assess the similarities and differences between 
glomerular and tubular basement membrane composition. It was demonstrated that 
mouse glomerular and tubular basement membrane share similar compositions but differ 
with respect to specific amounts of some components. 
In diabetes mellitus and passive Heymann nephritis (PHN) , damage to the 
glomerular barrier occurs and is accompanied by an increase in penneability to proteins 
the size of albumin and larger: Presumably, the biochemical nature of the filter is not 
maintained. The acute effects of streptozotocin diabetes and PHN on the macromolecular 
composition of rat GBM was investigated to determine if changes in composition 
correlated with proteinuria in these two models of kidney disease. Diabetes and PHN 
were shown to have differential effects on GBM composition during the establishment of 
proteinuria. Diabetes affected the GBM macromolecular composition; a significant 
reduction in anionic charge content correlated with significant proteinuria and significant 
increases in both laminin and fibronectin that occurred during the period immediately 
following proteinuria. However, PHN had no effect on the GBM macromolecular 
composition despite overt proteinuria after five days. 
VI 
These results suggest that the stimuli that lead to changes in GBM composition in 
diabetes are likely related to those which result in proteinuria; however, there appears to 
be no relationship between the GBM composition and overt proteinuria in PHN, or the 
mechanisms for the induction of proteinuria between diabetes and PHN. 
I. INTRODUCTION 
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Basement membranes are a specialized form of extracellular matrix that underlie all 
epithelia, and surround adipocytes, peripheral nerves, and muscle fibers. Studies utilizing 
tumors that synthesize large amounts of basement membrane-like matrices, such as the 
mouse Englebreth-Holm-Swann (EHS) sarcoma, have been useful in determining the 
macromolecular composition of basement membranes; a number of these 
macromolecules, including type IV collagen [1], laminin [2], fibronectin [3], entactin [4], 
and heparan sulfate proteoglycan [5] have been characterized. Along with these 
macromolecules, it has been suggested based on electrophoretic examination that 
basement membranes contain many more proteins [6]. The structural architecture of 
basement membranes is composed of a backbone of type IV collagen to which attach 
laminin, fibronectin, entactin, and heparan sulfate proteoglycan resulting in a highly 
compact three-dimensional meshwork [7]. 
Basement membranes have been ascribed several functions: they help maintain 
tissue architecture by providing a sheet-like support to which cells attach, and influence 
cell growth and differentiation [8]. Basement membranes also function to 
compartmentalize tissues, orient and polarize epithelia, provide substrates for wo~nd 
healing and tissue regeneration, and restrict the passage of macromolecules [9]. The 
function as a filter is best described in the kidney in which the glomerular basement 
membrane provides the only continuous barrier between the blood and the urinary space, 
and selectively prevents large macromolecules from leaving the blood space. This 
function is believed to be related directly to the specific macromolecular composition and 
architecture of the glomerular basement membrane [10]. 
The understanding of the macromolecular composition and structural architecture of 
the glomerular basement membrane during normal conditions of health is of paramount 
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importance as alterations in composition have been shown to be intimately associated 
with various pathological states. The characteristic feature of altered basement 
membrane morphology in renal dis~ase is an increase in glomerular basement membrane 
width and expansion of mesangial matrix [11]. The functional abnonnality associated 
with this alteration is impairment of selective filtering with resultant proteinuria [11]. 
The appearance of proteinuria, indicates loss of nonnal kidney penneability. It has 
generally been assumed that the morphological and functional' alterations of basement 
membranes in human and experimental disease must be accompanied by associated 
changes in their chemical composition and structure. However, compositional analyses 
of human GBM and animal GBM in experimental disease have produced incomplete and 
contradictory data. 
Insulin-dependent diabetes mellitus, a metabolically induced disease, is 
characterized by progressive GBM thickening and proteinuria in later stages. There is 
evidence that diabetic glomerular basement membrane undergoes distinct compositional 
changes [12]; however, specific macromolecular changes have yet to be directly 
correlated with the onset of the functional alterations. 
Passive Heymann nephritis, an immunologically-induced animal model of human 
membranous glomerulonephritis, is characterized by progressive GBM thickening and 
rapid onset of severe proteinuria [13]. However, very little data is available on alterations 
of GBM components in this disease. Although diabetes mellitus and passive Heymann 
nephritis share thickened GBM and proteinuria, the rates of induction and the degrees of 
proteinuria are extremely different. Furthermore, changes in the macromolecular 
composition of glomerular basement membrane have been implicated in the pathogenesis 
of proteinuria in both diseases; however, the specific mechanisms are unknown [13,14]. 
Thus, the precise localizations and amounts of these components within the basement 
membrane warrant extensive study_ 
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Most studies of basement membrane composition have involved electron 
microscopy in conjunction with immunostaining. These studies are useful in detennining 
the localization of basement membrane components; however, these techniques do not 
permit determination of absolute concentrations. of various components of basement 
membranes. The assessment of known as well as unknown components requires 
solubilization of the basement membrane. This structure has been shown to be highly 
cross-linked and relatively insoluble by conventional solubilization techniques [8]. Thus, 
the inclusions of strong denaturants and reducing agents are required to solubilize the 
basement membrane components [15]. Mohan and Spiro [15] have developed a 
technique that sequentially solubilizes the basement membrane components: The frrst 
step involves sonicating the membrane in the presence of guanidine-Hel, a denaturant, to 
solubilize attached proteoglycans and various glycoproteins. The second step 
incorporates dithiothreitol, a reducing agent, with the guanidine-Hel and sonication to 
solubilize any remaining glycoproteins leaving an enriched type IV collagen pellet. And 
finally SDS with sonication solubilizes this collagenous material to a limited extent. This 
sequential extraction procedure conveniently fractionates the complex and numerous 
components of the basement membrane. Subsequently, both known and unknown 
components in these fractions can be qualitatively and quantitatively evaluated using 
standard electrophoretic and immunoblotting methods and quantitation of specific 
components using solid-phase immunoassays. 
The overall goal as outlined in this dissertation was to determine the compositional 
heterogeneity in healthy isolated kidney basement membrane and then to assess, using 
two animal models whereby similar functional changes have occurred in the kidney 
filtration barrier, if changes in isolated GBM composition correlate with observed 
functional changes in diseased states. The frrst part of this goal involved the isolation of 
glomerular and tubular basement membranes from the same kidneys of healthy mice and 
subsequently to: 
1. Qualitatively assess differences in solubilized basement membrane 
components between the glomerular and tubular basement membranes 
using SDS-PAGE and imrnunoblotting techniques. 
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2. Quantitatively assess differences in the amounts of extracted laminin 
and fibronectin between the glomerular and tubular basement membranes 
using inhibitory ELISA. 
To assess the second part of the goal, the following hypothesis was tested: Changes 
in the macromolecular composition of isolated GBM correlate with proteinuria in both 
streptozotocin-induced diabetes and immunologically-induced passive Heymann 
nephritis (PHN) in rats. To test this hypothesis, the following specific objectives were 
proposed: 
1. Qualitatively assess differences in the macromolecular compositions 
between the GBM in diabetes and PHN by gel-electrophoresis and 
immunoblotting techniques. 
2. Quantitatively assess differences in type IV collagen, laminin, 
fibronectin and entactin content between the GBMs in diabetes and PHN 
using inhibitory ELISA. 
3. Quantitatively assess the anionic charge between the GBMs of rats with 
diabetes and PHN. 
4. Qualitatively assess the purity of the isolated GBM to detennine if 
loss of basement membrane components occurred during isolation 
procedures. 
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Studies of insulin-dependent diabetes mellitus and passive Heymann nephritis thus 
far have failed to evaluate changes in GBM composition in the acute phases of these 
disease models, specifically looking at the pathogenesis of these diseases. Thus, the 
novel feature of the study summarized in this dissertation is the assessment of GBM 
composition with the pathogenesis of two animal models of kidney disease that share a 
similar functional change. 
n Background 
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A MACROMOLECULAR COMPOSITION OF BASEMENT MEMBRANES. 
Type IV Collagen 
Basement membranes are formed by a fine network of cords that are woven 
together and associate with molecules such as laminin~ entactin!nidogen and heparan 
sulfate proteoglycan [7]. This network is made up of a type IV collagen skeleton [16]. 
Existence of two type IV collagen chains~ al(N) and a2(IV), have been known for some 
time and these are referred to as the classical chains [17]. Recent evidence for the 
presence of three additional chains in some basement membranes has been obtained 
through partial characterization of two chains bearing the epitopes responsible for 
Goodpasture's syndrome, an autoimmune disease affecting particularly the GBM, and 
through the cloning of a cDNA encoding another basement membrane chain [18-21]. 
These three novel chains have been given names a3(IV), a4(IV) and a5(IV). The 
a5(N) chain recently was shown to be defective in Alport's syndrome, a heritable 
condition resulting in severe kidney dysfunction [22]. 
The monomeric or protomeric structure of type IV collagen is composed of the 
classical collagen chains [a1(1V)2a2(N)] and possesses three distinct domains: a small 
helical N-terminal domain (7S), C-terminal globular domain (NC-1) and the central 
major helical domain [23] (Fig. II.1). As found in fibrillar collagens (types I, II, and III), 
the major helical and 7S domains have over the greater part of their length Gly-x-y 
repeats. In contrast to these fibrillar collagens~ which are rigid inflexible rods, type IV 
collagen has several nonhelical interruptions throughout the major helical domain [24]. 
These interruptions are believed to impart the flexibility observed in this collagen 
molecule [24]. Type IV collagen monomers can assemble to form stable three 
dimensional structures using three types of interactions [25]. First, disulfide bonds can 
fonn between the NC-l domains of two separate monomers. Second, the 7S domain of 
one monomer can bind to three other monomers in an antiparallel overlapping association 
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thus forming a tetrameric structure. This arrangement is stabilized by disulfide bonds and 
hydrophobic interactions. Finally, collagen dimers associate through lateral interactions 
fonning a polygonal network [25]. 
One of the fIrst roles assigned to type IV collagen was the association of monomers 
fonning large supramolecular aggregates thus generating supportive structures [8]. 
Recently, this molecule has been shown to bind to laminin, entactin/nidogen, 
proteoglycans, and various cells [25]. The biological activity of type IV collagen has 
been studied in several environments. Sympathetic neurons plated on type IV collagen 
exhibited neurite outgrowth, a characteristic feature of neuronal growth. Further study 
revealed that the NC-l domain was the epitope for this neuronal activity [26]. Another 
area of intensive research is in the f'mding that several tumor cell lines attach directly to 
type N collagen, presumably an important mediator in cancer cell metastasis [27]. 
Laminin 
Laminin was initially isolated and characterized from the murine EHS tumor [2]. 
Since then, laminin has been isolated in naturally occurring basement membranes and is 
currently recognized as being a family of large, multidomain, isomeric glycoproteins and 
because of this the prototypic EHS laminin molecule is now referred to as "classical" 
laminin [25]. Classicallaminin is composed of three genetically distinct polypeptide 
chains designated as Ae, Ble and B2e. These three chains assemble to form an 
asymmetric cross shape with three short arms and one long arm (Fig. IT.I) [28]. Each of 
the two short arms contains a central and terminal globular domain while the long arm 
contains two central and a terminal globular domain at each end [28]. From limited 
proteolysis of classicallaminin, several fragments or domains with specific biological 
activities have been discovered [8]. The ends of the short arms bind to regions of type IV 
collagen and the long ann binds to heparan sulfate proteoglycan [8]. The pepsin derived 
fragment, PI, contains segments of the short arms near the center of the cross. PI 
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contains two sequences of amino acids shown to be involved in cell binding with laminin, 
YIGSR and RGD, and dermes one of the two described cell binding domains [29]. The 
other cell binding domain is present in the elastase derived fragment, E8, which 
corresponds to a segment of the long ann and contains portions of all three chains. In 
addition, E8 also promotes neurite outgrowth, and may be responsible for maintaining 
cell polarity [30]. 
With monoclonal antibodies and cDNA cloning techniques, isofonns of laminin 
were discovered. Original studies revealed the non-synchronous expression of the Ae, 
Ble, and B2e chains during early development. Ble and B2e chains were identified at 
the four to eight cell stage, while the Ae chain was not detectable until the sixteen cell 
stage of mouse embryos [31]. Other studies revealed that laminin isolated from various 
sources consisted of different structures: polypeptide chain substitution or lacking one of 
the three chains. S-laminin was detected with monoclonal antibodies that selectively 
stained synaptic basement membranes [32]. Cloning of S-laminin revealed extensive 
homology with both mouse laminin Be chains; however, the homology to Ble is greater 
than to B2e. Thus, S-laminin is now referred to as Bis [25]. Immunofluorescence 
studies revealed the presence of S-laminin in glomerular but not tubular basement 
membrane [32,33]. An isofonn of laminin A chain was discovered in extracts of human 
placenta [34]. This new molecule, initially named merosin, has been shown by partial 
sequence analysis to be homologous to the laminin Ae chain and thus is now referred to 
as laminin Am chain [25]. 
Laminin can polymerize through terminal globular domains of all four anns of the 
cross and the polymerization is Ca++ dependent. Apart from type IV collagen, laminin is 
the only basement membrane component known to polymerize; this may be an important 
function particularly in basement membranes lacking type IV collagen [35]. Yurchenco 
et al recently revealed that this laminin self-association is necessary for the architectural 
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maintenance of the collagen-free basement membrane of cultured. embryonic carcinoma 
cells [36]. 
Fibronectin 
Fibronectin is a glycoprotein that exists as two forms, either as a soluble plasma 
fonn or as an insoluble cellular fonn [8]. While its presence has been observed in many 
basement membranes, some authors propose that it is simply a molecule entrapped within 
the membrane [37]. Most immunohistochemistry data suggest that fibronectin is a 
component of basement membranes [9]. Fibronectin is a dimer of two similar or identical 
chains that are linked at their C-termini by disulfide bonds (Fig. 11.1). Each chain is 
defined by a number of functional domains. Some of these domains include binding sites 
for cellular receptors, fibrin, DNA, collagen, and beparan sulfate [9]. The cellular and 
plasma forms of fibronectin are almost identical, originating from the same gene; 
however, alternative splicing of the transcript inserts two additional domains, E3A and 
E3B, into the cellular fonn [8]. A central cell-binding domain or 75 Kd fragment exists 
in both fonns of fibronectin and contains the sequence ROD, identified as the minimal 
amino acid sequence recognized by a number of integrin receptors [38]. 
Fibronectin has been shown to play a role in cellular adhesion, either between cells 
[39] or between cells and the extracellular matrix [40]; and the adhesion plaques 
represent the anchorage of extracellular fibronectin to the intracellular microfllaments of 
actin [41]. Recently it has been demonstrated that this interaction is mediated by the 
integrin fibronectin receptor [42]. Fibronectin may playa role in the transmission of 




Entactin and nidogen were isolated from two different mouse tissue sources and 
thought to be different molecules; however, sequencing data demonstrated that the two 
molecules were identical [43]. These molecules are currently referred to as 
entactin/nidogen [25]. Entactin/nidogen is a sulfated. glycoprotein and has the shape of a 
dumbbell, consisting of two globular domains connected by a short rod-like segment [35] 
(Fig. 11.1). This molecule is broken down into three domains: Domain I is the N-
tenninal globular domain, domain IT is the rod-like portion, and domain III is the C-
tenninal globular domain. Domain IT has been shown to contain five consecutive 
epidermal growth factor-like repeats (cysteine-rich repeats) [25]. 
Entactin/nidogen forms tight, noncovalent complexes with laminin. These 
complexes are a result of the globular domain In of entactin/nidogen binding to the inner 
segment of one short ann of laminin Bl chain [35]. This complex fonnation imparts on 
entactin/nidogen an increased protease resistance. This molecule has also been shown to 
bind to type IV collagen. However, the binding of entactin/nidogen to type IV collagen is 
not as strong as the binding forces with laminin [44]. This interaction has led to the 
suggestion that entactin/nidogen may act as a major bridging protein [35]. Furthennore, 
this molecule contains an ROD sequence and has been shown to support cell adhesion and 
to bind calcium ions [45]. 
Proteoglycans 
Proteoglycans are a class of macromolecules characterized by a protein core to 
which glycosaminoglycans are coyalently bound. It is the type of glycosaminoglycan that 
defmes the class of proteoglycan: keratan sulfate, dennatan sulfate, chondroitin sulfate 
and heparan sulfate. Furthermore, the number of attached glycosaminoglycans and size of 
protein cores can vary considerably for each class of proteoglycan, thus giving rise to 
isofonns within each class. TIle glycosaminoglycans are long linear polymers composed 
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of a repeating disaccharide sequence, usually a sulfate-substituted amino sugar and an 
uronic acid. Because of the sulfate groups on most of the sugar residues, 
glycosaminoglycans are highly negatively charged [46]. 
Heparan sulfate is the most predominant glycosaminoglycan (85%) found in renal 
basement membrane proteoglycans; however, small amounts of chondroitin sulfate (15%) 
are also present [47]. Two forms have been isolated from the EHS tumor, a low density 
fonn with a large protein core and a high density form with a small protein core (Fig. 11.1). 
The low density form consist of a 500 Kd protein core to which three heparan sulfate 
chains attach to one end [25]. The high density form has a small 18Kd core protein with 
four heparan sulfate chains [25]. Similar, but not identical, heparan sulfate proteoglycans 
have been isolated from GBM. These molecules are similar at the immunological level 
but differ with respect to size of protein core and degree of sulfation. For example, a high 
molecular weight fonn from bovine GBM was found to consist of a 200 Kd core protein 
with four heparan sulfate chains attached to one end [48]. 
Heparan sulfate side chains can bind to laminin and type IV collagen, modulating 
their capacity to self-associate [49]. Heparan sulfate proteoglycan-Iaminin interactions 
resulted in an augmentation of laminin aggregate formation. Heparan sulfate proteoglycan 
induced laminin complexes were more densely arranged than normal. Conversely, 
heparan sulfate proteoglycan binding to type IV collagen resulted in the inhibition of 
normal lateral associations of type IV collagen and subsequent network formation [50]. In 
the GBM, heparan sulfate proteoglycans are thought to serve as the major charge-
permselective barrier due to the anionic charge of the sulfated glycosaminoglycans [51]. 
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B BASEMENT MEMBRANE STRUCTURAL AND FUNCTIONAL 
RELATIONSHIPS. 
Electron microscopy studies of the glomerular basement membrane reveal the 
presence of three distinct layers: an electron-dense layer tenned the lamina densa, and 
two electron-lucent layersy the laminae rarae, opposing each side of the lamina densa [9] 
(Fig. ll.2). Innumerable immunoelectron microscopy studies have been conducted on the 
glomerular basement membrane and have suggested restricted localizations in the three 
defined layers for the above-mentioned macromolecules. One group of investigators 
argued that these layers were an artifact of fixation [52]. It was shown that when using 
rapid-freezing with freeze-substitution a single homogeneous layer was revealed instead 
of the three defined layers. Unfortunately, no immunostaining studies were done on this 
freezed-flXed tissue to detennine if the macromolecular components were also distributed 
homogeneously. Other studies have revealed that the mode and stringency of fIXation 
affects the appearance and relative thicknesses of the three layers; however, the layers are 
always present [7]. Nevertheless, support for the homogeneous basement membrane is 
scarce and examination of the basement membrane using a chemical fixative with 
subsequent transmission electron microscopy is the standard technique. High resolution 
electron microscopy" studies have given rise to several proposed models of basement 
membrane architecture. 
The most accepted model thus far is one of Yurchenco and coworkers [24]. In this 
model, the superstructure or backbone of basement membrane is a network of type IV 
collagen upon which other components attach. As described earlier, type IV collagen can 
associate through three processes to form this backbone: C-terminal dimerization, 7S 
amino tenninal tetramerizations, and lateral associations. These three interactions are all 
II 
stabilized through covalent cross-links resulting in a three-dimensional meshwork. 
Laminin polymers, formed through interactions between the ends of the short and long 
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arms can then attach to the collagen meshwork directly or through entactinlnidogen 
bridges. Heparan sulfate proteoglycan has been shown to form oligomers through core 
protein interactions. The free ends of the heparan sulfate side chains can bind weakly to 
the laminin long arm globular domain and type IV collagen [35]. The affinity of laminin 
binding to heparan sulfate chains is influenced by the degree of sulfation., such that a 
higher sulfate content of the heparan sulfate glycosaminoglycans results in stronger 
binding to Iaminin [53]. From tissue culture studies, evidence for strong binding of 
laminin with the core protein of beparan sulfate proteoglycan exists; however, this 
protein-protein interaction has not been demonstrated in vivo [54]. In a high resolution 
immunoelectron microscopy study of the GBM, Laurie et al demonstrated a network of 3-
4 nm cords [7]. These cords were centered by type N collagen, surrounded by laminin, 
fibronectin and heparan sulfate proteoglycan macromolecules. Although these results 
support the Yurchenco model, it is important to point out two limitations of this model for 
basement membrane architecture: 1) inability to explain the three layers observed in 
chemically fixed basement membrane, and 2) the inability to match the small theoretical 
pore size, of 9 run [24]. 
Basement membranes were originally thought only to provide an underlying support 
for tissue, yet evidence now suggests that the number of functions defined for basement 
membranes are continually increasing. Some of these functions are: compartmentalize 
tissues, provide support to which cells can attach, influence cell shape, growth and 
differentiation, and act as a molecular sieve. Compartmentalization and structural support 
of tissue occurs throughout the human body. The basement membrane of the skin serves 
to provide a resilient scaffold to which epithelial cells attach and also serves to segregate 
the epidennis from the underlying dermis. Glomerular basement membrane serves to 
maintain cell shape and orient cell polarity. In one study, when glomerular epithelial cells 
were cultured and plated on collagen gel matrix, they attached, flattened out and secreted 
basement membrane constituents from the basolateral surfaces [55]. When, these cells 
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were treated with ammonium chloride, known to disrupt secretion in polarized cells, 
secretion of the basement membrane components occurred on the apical surface as well 
[55]. The attachment of cells to the basement membrane occurs through interactions with 
transmembrane matrix-binding proteins on cell surfaces [25]. The best example of this 
process are the integrin receptors for basement membrane components as described 
earlier. For example, antibodies to the a6 integrin subunit (interacts with the E8 fragment 
of laminin) inhibited the inductive formation of kidney epithelia in kidney organ cultures. 
The importance of attachment of cells to the basement membrane was demonstrated [56]. 
During the process of nephron development, the interaction of cells with the basement 
membrane is essential for the completion of conversion and morphogenic events [57]. In 
studies of mouse nephrogenic mesenchyme, only small amounts of laminin B chain were 
present in these undifferentiated cells. At the time of epithelial conversion of the 
mesenchyme, the laminin A chain, type IV collagen and heparan sulfate proteoglycan 
abruptly appeared [57]. 
Alterations in these components have been implicated in various renal diseases. For 
example, in autosomal recessive polycystic kidney disease there is altered gene expression 
of basement membrane components during kidney development [58]. Initially, alterations 
in laminin B chains and type IV collagen mRNA from whole kidneys resulted in 
abnormally low levels, whereas immunostaining for the proteins appeared normal. 
Subsequently, the levels for these mRNAs were excessively high and immunostaining was 
weakly detectable~ Morphologically, the developing proximal tubules appeared dilated, 
and the basement membrane was thickened. 
The importance of the basement membrane acting as a perm-selective filter cannot 
be emphasized enough in the kidney. The glomerulus filters the blood producing a 
protein-free ultrafiltrate of the blood plasma [9]. This specialization depends on the 
collective contribution of three components: the endothelium, glomerular basement 
membrane, and the epithelium [59]. The size and charge selective capacity of the GBM 
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has been determined from clearance studies of neutral and charged dextrans of various 
sizes. In one such study, size discrimination was demonstrated by the increasing 
restriction to filtration with neutral dextrans of increasing molecular radius [60]. In 
addition, charge discrimination was observed when negatively charge dextran sulfates 
were restricted while positively charged DEAE (diethylaminoethyl) filtration was 
increased. From these studies, the GBM was assigned a 66,000 Dalton molecular weight 
cut-off, a pore size of 3.6 nm in diameter for filtration, and it was estimated that 
macromolecules the size of albumin and larger were prevented from passage. 
Alternatively, Schnitzer calculated the minimum effective "pore" radius to be 5.7 nm 
based on collagen IV molecules having a 0.07 nm radius [61]. This reevaluation of the 
theoretical "pore size" was performed using the fiber-matrix model, a more consistent 
model in light of the architecture of basement membranes; however, this model only 
reflects theoretical calculations and not what gets through. The presence of "pores" have 
not been demonstrated in GBM. 
The size selective nature of the OBM is believed to be imparted by the tbree-
dimensional meshwork composed of a type IV collagen backbone to which other 
basement membrane constituents are attached [7]. The increased permeability to 
positively charged macromolecules combined with the use of cationized probes 
demonstrated that the GBM was negatively charged [60]. Rennke et al [62], demonstrated 
that, whereas anionic ferritin did not penetrate, cationized ferritin penetrated to a great 
extent into the GBM. Various stains, for example ruthenium red [63], were used to detect 
anionic sites in the GBM and, in conjunction with enzymatic studies selectively degrading 
the anionic constituents, the importance of sulfated glycosaminoglycans in glomerular 
charge perm-selectivity was established [64,65]. 
It is generally understood that basement membranes are heterogeneous with respect 
to composition as will be demonstrated in chapter three [66]. Perhaps differences in the 
relative concentrations of individual constituents may result in different permeability 
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properties in these basement membranes. Thus, it is possible that differences in 
permeability properties of various segments of the nephron may be influenced by 
heterogeneous basement membranes underlying the tubular epithelium. 
C BASEMENT MEMBRANE ALTERATIONS IN DIABETES MELLITUS. 
The remarkable specialization of the kidney as a macromolecular sieve is 
undoubtedly due to the particular organization of the glomerular barrier, mainly the 
fenestrated endothelial cells, the glomerular basement membrane and the epithelial cells 
which generate the slit pores (Fig. ll.2). As mentioned above, the GBM is a highly 
crossed-linked three-dimensional meshwork that imparts a size and charge selective 
capacity to the OBM. In diabetes mellitus, loss of selective penneability with proteinuria 
constitutes one of the major characteristics of diabetic nephropathy_ It is believed that 
progressive accumulation of glomerular extracellular matrix, both glomerular basement 
membrane and mesangial matrix, is an important aspect of the defect that leads to 
proteinuria and ultimately to glomerular sclerosis with loss of functioning filtration units 
[59]. It has been commonly assumed that these morphological and functional alterations 
of the glomerular basement membrane in human and experimentally induced diabetes 
must be accompanied by changes in their macromolecular composition and structure 
[67].· A number of mechanisms have been proposed to explain the thickening of 
glomerular basement membrane: increased synthesis, decreased degradation and 
removal, or an accelerated turnover of basement membrane synthesizing cells [67]. 
In general, two approaches have been used to study alterations of glomerular 
basement membrane in diabetes: 1) compositional analysis of isolated GBM from 
human or experimental animals and 2) biosynthesis of basement membrane by either 
whole glomeruli, renal cortex, or cultured cells isolated from the glomerulus. Evidence 
that the human GBM undergoes distinct compositional changes in diabetes was initially 
19 
(1970) obtained from amino acid and carbohydrate analyses, which indicated that 
constituents associated with collagen (hydroxyproline and hydroxylysine) were 
significantly elevated while the level of glucouronic acid, a component of 
glycosaminoglycans, was decreased [68]. Furthermore, analyses of whole glomeruli 
demonstrated that the content of basement membrane material was substantially elevated 
above the nonnal in diabetes [69]. In contrast, subsequent studies failed to confinn these 
differences [70-72]. These studies indicated that the relative proportion of hydroxylated 
amino acid residues increased, but not significantly, implying that synthesis of all 
components was increased or that turnover was decreased. Thus, based on these studies, 
whether statistically significant or not, it is generally believed that there is an increase in 
the relative hydroxylated amino acid content in diabetic GBM over control, suggesting an 
enrichment of the basement membrane by the collagen component. 
Measured amounts of laminin, fibronectin and entactin in diabetic GBM have not 
been clearly demonstrated. Shimomura and Spiro [12] showed a significant reduction in 
the amount of laminin in human diabetic GBM, while in diabetic mice laminin was 
increased [73]. In addition, mRNA levels for laminin Bl chain were significantly 
increased in streptozotocin diabetic rats [74]. Amounts of fibronectin measured in human 
diabetic GBM were unchanged [12]; however, cultured glomerular endothelial cells 
exposed to high glucose concentrations resulted in increased expression of fibronectin 
mRNA [75]. Amounts of GBM entactin have not been measured in human and 
experimental models of diabetes. 
The functional significance of these altered GBM components has not been 
established. Furthennore, it has yet to be demonstrated that thickened GBM directly 
correlates with changes in filtration. It has been suggested that compositional changes 
lead to alterations in the interactions of the GBM constituents. Therefore, these 
alterations may induce modifications in the three-dimensional architecture of the 
20 
basement membrane and could be responsible for the loss in pennselectivity in the 
glomerular barrier resulting in proteinuria [14]. 
The sulfated glycosaminoglycans (heparan sulfate being predominant) in the 
glomerular basement membrane constitute anionic sites that regulate the charge selective 
barrier, and have been implicated in the pathogenesis of proteinuria occurring in diabetes 
and other proteinuric states [76]. Decreased content and synthesis of heparan sulfate 
pro teo glycan has been reported in diabetic rats and humans [73,77]. Another study 
demonstrated not only a decrease in synthesis of hepa.raIi sulfate proteoglycan in diabetic 
glomerular basement membrane, but also a change in the type of heparan sulfate that was 
present [11]. The change in the diabetic glomerular heparan sulfate probably represented 
a different and newly synthesized beparan sulfate. 
From this brief survey, it can be concluded that alterations in GBM composition 
occur. However, it is unclear when these changes occur, particularly with respect to the 
onset of proteinuria. 
D BASEMENT MEMBRANE ALTERATIONS IN PASSIVE HEYMANN 
NEPHRITIS. 
Passive Heymann nephritis (PHN) is an animal model that closely resembles human 
membranous glomerulonephritis [13]. The characteristics of this disease are thickened 
GBM, marked mesangial expansion and severe proteinuria [78]. PHN is induced by 
administration of a single injection of anti-FxlA antibody. This antibody, generated in 
sheep, is directed against rat tubular brush border and cross-reacts with an antigen on the 
surface of glomerular epithelial cells [79]. As a result, subepithelial immune deposits 
form and within one week severe proteinuria occurs followed by progressive GBM 
thickening and mesangial expansion [13]. GBM compositional studies in PHN are scarce: 
Type IV collagen, laminin, fibronectin and entactin have not been quantitated in 
glomerular basement membrane from rats with passive Heymann nephritis. However, the 
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mRNA levels for collagen IV, laminin and fibronectin were measured and found not to be 
different from control values [80]. Although no_ significant differences were measured in 
the mRNA levels, this does not preclude the possibility that the protein products or that 
assembly of these components were altered in the glomerular basement membrane. Some 
support for altered assembly was shown by immunoelectron microscopy of antibodies to 
laminin B2 chain. These antibodies stained in a pattern that surrounded the immune 
deposits. This suggested that these deposits displaced the GBM resulting in altered 
organization of the immediate GBM architecture. Such alterations could then lead to 
increased penneability of the GBM. 
Some immunostaining studies have been conducted on biopsy tissue of patients 
with membranous glomerulonephritis characterizing the distribution of type IV collagen, 
laminin and fibronectin in the GBM. In an immunofluorescence study, Fukatsu et al [81] 
demonstrated that antibodies to type IV collagen reacted preferentially with the inner and 
outer aspects of the thickened GBM, while antibodies to laminin reacted in the same 
manner as type IV collagen but additionally reacted with subepithelial OBM spikes and 
in newly fonned GBM above the immune deposits. Thus, it was concluded that type IV 
collagen and laminin did not codistribute in the newly fonned matrix. Laminin was in 
both the subepithelial spikes and in the GBM enveloping the immune deposits. 
Fibronectin has been localized in the immune deposits in the GBM as revealed by 
immunoelectron microscopy [82]. 
Another study examined the localization of classical and novel chains of type IV 
collagen, laminin B2 chain, fibronectin, and entactin/nidogen during the development of 
membranous glomerulonephritis [83]. No difference in staining for the components was 
observed at stage I of the disease in which small immune complexes were detected 
without morphological changes to the OBM. By stage IT, immune deposits had increased 
in size and frrst signs of GBM invaginating (spikes) these deposits were apparent, an 
alteration in immunostaining was detected. The subepithelial spikes or projections and 
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areas of thickened GBM demonstrated significant staining for the novel chains [a3(1V) & 
a4(IV)] of type IV collagen, laminin B2 chain and entactin/nidogen, but no changes in 
the staining of classical chains [a 1 (IV) & a2(IV)] of type IV collagen or fibronectin. In 
stage ill, the immune deposits were completely embedded in the GBM, which displayed 
marked thickening. Staining of the aforementioned components continued to increase 
with an increase in staining for the classical collagen chains and fibronectin now 
demonstrable. In summary, after deposition of immune deposits in the subepithelial side 
of the GBM'J this membrane sent projections up and around the deposits. These 
projections consisted predominantly of novel chains of type IV collagen, laminin and 
entactin/nidogen that eventually enveloped the immune deposits. Ultimately, this process 
yielded a thickened subepithelial GBM with a subsequent increase in the type IV collagen 
classical chains and fibronectin in the subendothelial side. The end result was an overall 
thickened GBM. 
It is interesting to reiterate that Fogel et al [80] detected no changes in mRNA 
levels for type IV collagen'J laminin or fibronectin despite the presence of immune 
deposits and thickened GBM. This discrepancy may be due to the mRNA analysis not 
being sensitive enough to detect an increase; alternatively, the stability of the specific. 
mRNAts may have been enhanced resulting in increased translation. 
Exploratory work on the heparan sulfate proteoglycan content has been conducted 
in a model of human membranous glomerulonephritis [84]. Subepithelial immune 
deposits were induced in rabbits by daily administration of cationized bovine serum 
albumin. These deposits resulted in thickened OBM morphology with severe proteinuria 
after three weeks. It was demonstrated that no change in total glycosaminoglycan content 
occurred, but the sulfation state of heparan sulfate was altered. There was a 20% 
decrease in incorporated labeled sulfate measured in isolated heparan sulfate despite no 
change in the total amount of this glycosaminoglycan. Further study revealed that this 
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altered glycosaminoglycan had a lower effective charge and corresponded with a loss of 
charge-selective capacity in fractional clearance studies with charged dextrans [84]. 
This brief historical description is: meant to illustrate the limited and inconclusive 
results on glomerular basement membrane compositional alterations in passive Heymann 
nephritis. 
Figure 11.1 Structural models of type IV collagen, laminin, fibronectio, 
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Figure IL2 Schematic representation of the glomerular barrier in the kidney. It 
is composed of fenestrated endothelial cells, glomerular basement membrane, and 
foot processes of the podocytes/epithelial cells. This remarkable organization 
imparts to the kidney the ability to selectively retard the passage of 
macromolecules from leaving the capillary lumen based on size and charge. I.r. 
int. = lamina rara interna, 1. den. = lamina densa, I.r. ext. = lamina rara externa. 








DI. HETEROGENEOUS MACROMOLECULAR COMPOSITION OF MOUSE 
GLOMERULAR AND TUBULAR BASEMENT MEMBRANE 
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SUMMARY 
Renal glomeruli and tubules were isolated from eight-week-old Swiss-Webster 
mice by sucrose-gradient centrifugation. Glomerular basement membrane (GBM) and 
tubular basement membrane (TBM) were isolated by sonication in 1 % deoxycholate. 
GBM and TBM were subjected sequentially to 5M guanidine, 5M guanidine/20mM 
dithiothreitol (DTI) , and 2% sodium dodecyl sulfatelDTT (SDS/DTI) extraction 
procedures. Electrophoresis revealed a complex mixture of proteins in the guanidine and 
guanidinelDTT extracts, while in the SDSIDTT extract, electrophoresis revealed two 
strong-staining bands that corresponded to chains of type IV collagen. Immunoblot 
analysis demonstrated that among the proteins, laminin and fibronectin were found 
exclusively in the guanidine and guanidinelDTI extracts. Laminin and fibronectin were 
quantitated in these extracts using inhibitory ELISA. The total amount of laminin 
extracted in GBM, 1.8±O.OOI J..1g/mg dry weight (n=2 groups of 53 animals), was 
significantly less than in TBM, 3.4±o.1 J.1g/mg dry weight (n 2); however, the total 
amount of fibronectin extracted did not differ between GBM and TBM, 8.2±O.8 J.1g1mg 
dry weight and 7.7+1.0 flg/mg dry weight (n=2) respectively. We conclude that GBM 
and TBM are qualitatively similar but differ significantly in content of one and probably 
more macromolecular components. 
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INTRODUCTION 
A number of macromolecules (laminin [2], fibronectin [3], type IV collagen [1], 
entactin [4], and beparan sulfate proteoglycan [5]) have been localized to basement 
membranes. Laminin, type IV collagen, and entactin have been shown to assemble into 
3-4nm diameter cords which subsequently form a three dimensional mesh-like 
architecture [86], while heparan sulfate proteoglycans are believed to act as space filling 
molecules and are responsible for the charge selectivity of basement membranes [65]. In 
the kidney, it is generally thought that the mesh-like matrix of the GBM is involved in 
selectively retarding the passage of macromolecules from the blood to the urinary space. 
How the GBM functions as this selective filter is poorly understood. Unfortunately, the 
direct study of intact GBM as a selectively permeable barrier is technically not possible 
to date. The permeability properties of basement membrane can be directly studied using 
intact isolated perfused TBM, possibly as a model for the glomerular barrier [87]. 
Although it is encouraging to think that the isolated TBM could be used as a model for 
the filtering properties of GBM, it is necessary to define the compositions of the two 
basement membranes and determine what components, if any, influence the permeability 
properties. Thus, understanding similarities and differences between glomerular and 
tubular basement membrane may enable the extrapolation of findings in the isolated 
perfused TBM to that of the GBM. 
Many researchers have used immunocytochemistry to examine the comparative 
distribution of basement membrane components. The production of specific polyclonal 
and monoclonal antibodies have revealed differences in labeling patterns in GBM and 
TBM, suggesting compositional and/or structural heterogeneity exists in these basement 
membranes. Desjardins and Bendayan [14], using specific polyclonal antibodies, 
revealed distinct heterogeneity in the distribution of laminin, type IV collagen, entactin, 
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and HSPG in GBM~ mesangial matrix, Bowman's capsule, proximal tubule and distal 
tubule basement membrane. 
While immunocytochemistry is the ideal technique for localization of specific 
basement membrane components, the results can be difficult to interpret in terms of 
differences in content: Discrepancies in immunostaining may be a result of routine tissue 
fixation masking antigenicity. Furthermore, the absence of immunoreactivity might not 
reflect absence of antigen, and the presence of immunoreactivity could result from the 
presence of a related antigen. 
Mohan and Spiro [15] are the only investigators to report amounts of solubilized 
GBM components. In comparing the GBM with the basement membrane of the lens 
capsule, they reported that, although laminin, fibronectin, type IV collagen, entactin, and 
heparan sulfate proteoglycan were present in the two basement membranes, differences in 
the relative amounts of these components were seen. GBM contained more fibronectin 
and type IV collagen, and less laminin and entactin than did the lens capsule basement 
membrane .. 
Knowledge from the present study of the macromolecular composition between 
GBM and TBM, in conjunction with other studies in our laboratory on the penneability 
properties of the TBM, will enable us to begin to assess the functional significance of 
differences seen between glomerular and tubular basement membranes. In this 
investigation, we are interested in the similarities and differences between the 
compositions of glomerular and tubular basement membranes in mouse kidneys. Using 
methods of sieve separation and density gradient centrifugation, intact glomeruli and 
tubule fragments were isolated from whole mouse kidneys. After cellular materials were 
removed using deoxycholate, glomerular and tubular basement membranes were isolated, 
and a sequential extraction procedure was used to solubilize the basement membranes. 
To assess compositional differences of unknown proteins, electrophoretic protein profiles 
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from extracts of GBM and TBM were compared, while amounts of laminin and 
fibronectin in GBM and TBM were quantitated using inhibitory ELISA. 
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MATERIALS AND METHODS 
Isolation of glomeruli and tubules. All isolation and extraction procedures were at 0-
4°C in the presence of the following protease inhibitors: ImM phenylmetbylsulfonyl 
fluoride, ImM EDT A., l~g/ml aprotinin, IJ.1g/mlleupeptin, and IJ!g/ml pepstatin. In each 
of two replicate isolation procedures, 53 mice (Swiss-Webster, 61-day-old., male, -22g, 
from Charles River) were used. Each animal was killed by cervical dislocation, and both 
kidneys were rapidly excised and immediately immersed in chilled phosphate buffered 
saline (PBS) containing O.5M sucrose, pH 7.4. Kidneys were decapsulated and the hilus 
cut away_ The kidneys were minced with a razor blade and subsequently forced through 
a #170 stainless steel sieve (pore size 9OJ.1m) using a metal spatula. The tissue was rinsed 
frequently with chilled O.5M sucrose solution while being forced through the sieve. The 
glomeruli and tubules were separated using density gradient centrifugation according to 
the procedure of Vancura et al [88] (Fig. 111.1). The pure fractions were pooled, washed 
three times with PBS (0.I5M NaCI, O.02M phosphate, pH 7.4) and repelleted each time at 
48,OOOg for 20 min. 
Isolation and extraction of basement membrane. Glomeruli and tubules were 
resuspended separately in PBS containing 1 % sodium deoxycholate at a volume of 
ImV50mg tissue wet weight. Samples were sonicated at 20 watts for lmin/3ml volume 
using a Cole-Panner model 4710 ultrasonic homogenizer with a 2mm probe. The 
sonications were perfonned stepwise for 1 minute followed by 1 minute of cooling, with 
the sample tube always on ice. After sonication the samples were centrifuged at 48,OOOg 
for 30 min; the sonication procedure was carried out two more times, and the resulting 
basement membrane pellets were transferred to 1.5ml centrifuge tubes, washed three 
times with water, and repelleted each time at 16,OOOg. The final GBM and TBM pellets 
were lyophilized and weighed. 
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GBM and TBM were subjected to sequential extractions according to a procedure 
modified from that of Mohan and Spiro [15] (Fig. ill.l). Purified basement membrane 
(2mg) was suspended in Iml 5M guanidine hydrochloride, sonicated for 1 minute at 20 
watts and extraction continued for three hours at room temperature on an end-over-end 
rocker. The samples were centrifuged at 16,OOOg for 20min, and the supernatants 
decanted. The pellets were resuspended in Iml of 5M guanidine using brief sonication, 
and then extracted overnight at 4°C. The following morning the samples were 
centrifuged and the supernatants collected and pooled with those of the previous day. 
The pellets were resuspended in O.5ml of 5M guanidine with O.02M dithiothreitol 
(guanidinelDm, and kept at room temperature for three hours on an end-over-end 
rocker, and centrifuged. Finally, the pellets were resuspended in O.5ml of 2% SDS, 
O.02M OTT, and incubated for 1 hour at 100°C. After cooling, the samples were 
centrifuged at 16,OOOg for 20min, and the SDSIDTT extract was decanted leaving small, 
insoluble pellets. 
Analysis of extracts. SDS polyacrylamide gel electrophoresis was performed using 
vertical slab gels [89]. Samples were electrophoresed on 6% gels with an overlying 4% 
stacking gel. Proteins were visualized by silver or transferred to a nitrocellulose 
membrane (Schleicher & Schuell) and immunoblot analysis was performed [90]. Briefly, 
proteins electrophoresed on SDS-polyacrylamide gels were transferred to a nitrocellulose 
membrane for 1 hour, 0.5A, l00V, at 4°C using a Bio-Rad wet transfer apparatus. 
Membranes.were equilibrated in tris-saline buffer (65 mM Tris-Hel, 0.5 M NaCI, pH 
7.5), for 15 minutes. Membranes were subsequently blocked in tris-saline buffer 
containing 5% nonfat dry milk for 45 minutes, and incubated with a primary antibody for 
1 hour. Following three ten minute washes in tris-saline buffer, bound antibody was 
detected by an anti-IgG coupled to horseradish peroxidase incubated for 1 hour. 
Following three 10 minute washes in phosphate buffered saline, proteins were visualized 
by reaction with diaminobenzidine and H202. Molecular weights of electrophoresed 
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proteins were estimated by migration relative to (in Oaltoos) prestained standards 
ovalbumin, 46,500; serum albumin, 77,000; b-galactosidase, 116,000; and myosin, 
205,000 (Bio-Rad, Melville, New York). 
Laminin and fibrooectin were quantitated using inhibitory ELISA's [91]. Briefly, flat 
bottom 96-well microtiter plates (Costar #3590) were coated with antigen. Specific 
antigen was diluted in 0.02M carbonate buffer, pH 9.6, allowed to adsorb to the wells at 
lOOf.1Vwell overnight at 4°C. To a second 96-well plate, serial dilutions of soluble 
antigen or dilutions of unknown samples, 60 J..1Vwell in phosphate buffered saline 
containing 0.05% Tween-20, were pre-incubated with a pre-optimized dilution of 
antibody, 6OJ..LVwell in phosphate buffered saline containing 0.05% Tween-20. These 
were incubated overnight at 4°C. After allowing the plates to warm to room temperature, 
the coated plate was dumped and washed three times with phosphate buffered saline 
containing 0.05% Tween-20. Subsequently, 100J..LVwell were transferred from the pre-
incubated plate to the corresponding wells on the coated plate. After a 1 hour incubation, 
the plate was dumped, washed three times with phosphate buffered saline containing 
0.05% Tween-20. This was followed by the addition of anti-rabbit IgG conjugated to 
horseradish peroxidase at 100J.1l/well for 1 hour. The wells were washed three times with 
phosphate buffered saline containing 0.05% Tween-20 to remove unbound antibody. 
100J..LVwell of ABTS (2-2 azino-di-(3etbyl benzothiazolin sulfone-6)(diammonium salt) 
substrate solution in the presence of H202 were added and allowed to react for 30 
minutes. The absorbance of the subsequent color reaction was measured in a 
spectrophotometer (Cambridge Series 750 Microplate Reader, Cambridge Technology, 
Inc.) at 414 om. Amounts of laminin and fibronectin were calculated from standard 
curves using AssayZap 2.0 (BIOSOFf, Ferguson, Missouri). 
Total protein of the three extracts was measured using a micro bicinchoninic acid 
assay (Pierce) with bovine serum albumin as the standard. Aliquots of the guanidine and 
guanidine/DTT extracts were dialyzed against 3M urea to remove guanidine and DTT, 
36 
which was shown to interfere with the micro BCA assay. Aliquots of the SDSIDTI 
extracts were dialyzed against PBS at room temperature to remove the DTf and some 
SDS. 
Source of antigens & antibodies. Polyclonal antibodies to laminin were raised in 
rabbits against laminin purified from EHS tumors [92]. Fibronectin and anti-fibronectin 
were from Telios Phannaceuticals (San Diego, California). The anti-rabbit IgO was from 
Pierce (Rockford, Illinois). 
Statistical Analysis. Analysis of variance was used to determine the significance of 
differences among extracts and between GBM and TBM. The statistical analyses were 
conducted using JMP 2.0 (SAS Institute Inc., Cary, NC). 
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RESULTS 
Isolation of glomeruli and tubules. The glomerular fraction consisted of a mixture of 
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capsulated and decapsulated glomeruli (Figures III.2A and ID.3A). By particle count, the 
glomerular fraction contained fewer than 8% tubule fragments, which were small, 
ranging from 20 - 40 Jl.m in length. The tubular fraction consisted of a mixture of tubule 
fragments ranging from 100 - 300 J..lm in length and small clumps of tubules, with less 
than 5% glomerular contamination (Figures In.2B and ID.3B). 
Sequential extraction of GBM and TBM. Figure ID.4 shows that the percentage of 
total protein extracted from GBM was significantly less than that from TBM, 29.9±0.4% 
and 42±9.1% (n=2 groups of animals) respectively. In addition, in both the guanidine 
and D1T extractions, significantly less protein was extracted from GBM than TBM, thus 
reflecting the difference in total protein extracted. No difference was observed in the 
amount of SDS/DlT-extracted protein from GBM and TBM. The extraction procedure 
affected the distribution of extracted protein such that guanidine accounted for the most 
and SDSIDTT accounted for the least in both GBM and TBM (Fig. 111.4). A small 
insoluble pellet remained after the extraction procedure. 
Electrophoresis and immunoblotting of extracts. Figure ID.S is of a silver stained gel 
that revealed different profiles of proteins among the guanidine, DTf and SDS/DTT 
extracts for both OBM and TBM. Among the more than 30 bands resolved in the 
guanidine extracts, strong staining bands at 200-210kD and at 220kD migrated alongside 
the laminin B chains and the reduced chains of fibronectin, respectively. Weaker staining 
of bands at about 400kD that migrated alongside the A chain of laminin was seen in the 
guanidine extracts for both GBM and TBM. The same silver-stained profile for the A 
and B chains of laminin and for fibronectin was observed in the guanidinelDTT extracts; 
however, in the SDSIDTT extracts of both GBM and TBM these bands were absent. 
Silver staining of the electrophoresed SDSlDlT extracts revealed two strong-staining 
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bands that correspond to the al and a2 chains of type IV collagen. The guanidine extract 
revealed several bands that stained with different intensities between GBM and TBM 
suggesting qualitative differences in composition (shown by arrowheads in Fig. ill.5). 
Blots with anti-Iaminin revealed the presence of the two B chains of laminin in the 
guanidine and guanidine/DlT extracts of both GBM and TBM (Fig. 111.6). The A chain 
of laminin, however, was only detectable in TBM. Staining for the A chain of laminin 
was barely detectable in the guanidine extract with much greater staining in the 
guanidinelDTI extract. Blots with anti-fibronectin revealed in both guanidine and 
guanidine/DTI extracts a doublet, at 220kD, that migrated alongside reduced fibronectin 
(Fig. 111.7). The immunoblots probed with anti-Iaminin and anti-fibronectin antibodies 
also detected smaller molecular weight bands, presumably fragments, in both GBM and 
TBM for the guanidine and guanidine/DTT extracts. No staining was detected on the 
immunoblots of the SDSIDTT extracts for either laminin or fibronectin, suggesting 
complete solubilization of these components with guanidine and DTT. 
Laminin and fibronectin quantitation. Laminin and fibronectin were quantitated in 
the guanidine and guanidinelDTI extracts using inhibitory ELISA. The SDSIDTI 
extracts were not assayed because of the lack of immunostaining (Figures 111.6 and m.7). 
Although the total amount of laminin extracted from GBM and TBM was small, the 
amount measured in TBM was two-fold greater than that in GBM (Fig. m.8). With the 
addition of DTT to guanidine, only a small amount of laminin was additionally extracted 
from GBM and TBM; conversely, the amount of fibronectin extracted with 
guanidine/D'IT was much greater than the amount extracted with guanidine alone, 
suggesting fibronectin contains a higher degree of reducible cross-links to other 
components of basement membrane. The total amounts of fibronectin extracted did not 
differ between GBM and TBM (Fig. 111.8). 
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DISCUSSION 
The method of using sucrose gradients proved to be very successful in separating 
pure fractions of glomeruli and tubules from the same mouse kidney [11]. For the 
isolation of mouse GBM and TBM and rat GBM, we modified the sonication method of 
Spiro [10] by incorporating an anionic detergent, deoxycholate. To our knowledge this is 
the frrst time sonication in the presence of deoxycholate has been used for the isolation of 
basement membrane. 
Solubilization of basement membranes. Not all of the deoxycholate-insoluble 
material (GBM & TBM) was solubilized in this study, but the residual pellets were small 
compared to starting materials. Mohan and Spiro [15], reported that a small amount of 
bovine GBM was insoluble to these -denaturing and reducing agents. Kefalides [59], 
reported that the most successful approach to solubilizing-without degrading-basement 
membranes, was the reduction of disulfide bonds in the presence of strong denaturants. 
The incomplete solubilization of GBM and TBM suggests that these basement 
membranes contain a high degree of nonreducible cross-links resulting in insoluble 
structures. 
In the present investigation, bands corresponding to laminin A and B chains and 
fibronectin were apparent in the guanidine and guanidine/DTf, but not in the SDS/DTT 
extracts. Electrophoresis also revealed the presence of 6 bands, presumably unknown 
proteins, with molecular weights ranging from 58-190kD that appeared to be in greater 
amount in TBM than GBM; while 2 bands were shown to stain more strongly in GBM as 
compared to TBM (Fig. 5). The absence of staining for these bands in immunoblots 
suggested that these lower molecular weight bands were not fragments of laminin or 
fibronectin, while the differential silver-staining suggests differences in the relative 
amounts of these proteins between GBM and TBM. The few strong-staining proteins 
resolved in the SDSIDTf extracts migrated alongside the al and a2 chains of type IV 
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collagen, suggesting that this extract contains reduced type IV collagen. This observation 
is supported by the findings of Mohan and Spiro [15], who concluded that essentially all 
non-collagenous macromolecules were solubilized in the guanidine and DTT extracts 
leaving a collagenous pellet that was relatively soluble in SDSIDTT. 
From immunoblot analysis in this study, laminin B chains were present in both 
GBMand TBM, whereas the A chain of laminin could only be detected in TBM. This 
indicates that the A chain of laminin, if present, may exist in an amount that is 
insufficient to detect. Kleinman et al [93] demonstrated that different subunit structures 
of the laminin molecule exist in tissues: B 1 chain mRNA levels were highest in whole 
kidney with little A chain mRNA. Furthermore, the lack of staining for A chain of 
laminin in GBM may also imply that an isoform of this chain may exist in GBM that is 
not present in TBM. Sanes et al [33], showed heterogeneity in the distribution of 
s-laminin, an isofonn of laminin Bl chain7 among renal basement membranes: s-laminin 
was present in ra~ human7 and rabbit GBM but not TBM of the same species. The 
immunoblots revealed the presence of fibronectin in both GBM and TBM. 
Quantitation of laminin and jibronectin. The total amount of laminin measured in 
the GBM was half that of TBM. Similarly, Courtoy et al [94] using 
immunocytochemistry, reported a lesser amount of laminin present in GBM as compared 
to TBM. The amount of laminin we measured in mouse GBM7 1.8J.1g/mg7 was very 
similar to the amount reported by Mohan and Spiro [15] from bovine GBM7 1.6J.1g/mg. 
No differences were found in the amounts of fibronectin extracted from GBM and TBM. 
This is in contrast to results of Courtoy et al [94] who showed immunostaining for 
fibronectin was more intense in GBM than TBM. The amount of fibronectin reported by 
Mohan and Spiro [15] from bovine GBM, 11.3J.1g/mg7 was slightly greater than our 
measurement from mouse GBM7 8.2J.1g/mg. 
In summary, we see differences in composition between mouse GBM and TBM. 
Laminin content is higher in TBM, and electrophoretic profiles suggest that quantitative 
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differences exist between TBM and GBM in the content of other proteins as welL Thus, 
penneability work with isolated basement membrane from tubules cannot automatically 
be extrapolated to the basement membrane in the filtration barrier of the glomerulus [87]. 
On the other hand, we do not know if differences in laminin content (for example) would 
affect basement membrane penneability. Clearly, more work in this area is needed if we 
are to understand the relationship between the composition and penneability of basement 
membranes. 
Figure 111.1 Method for the separation of glomeruli and tubules followed by 
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Figure Ill.2 Digitized video images captured from bright field light microscopy 
of suspensions of A: glomeruli purified on 1.74M/2.0M sucrose gradient, and B: 





Figure 111.3 Digitized video images captured from high magnification bright 
field light microscopy of a single A: glomerulus purified on 1.74M/2.OM sucrose 




Figure 111.4 Distribution of protein in sequential extracts of GBM and TBM. 
Mouse GBM and TBM were treated sequentially with 5M guanidine, 5M 
guanidine/20mM 011, and 2% SDSID1T as described in methods. The graph 
indicates for each treatment the percentage of protein extracted based on initial 
dry weight of basement membrane. Values are means + standard error, n = 6. G 
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Figure 111.4 
Figure Ill.5 Solubilized components of GBM and TBM. Equal quantities (about 
3flg/lane) of guanidine (Gu), guanidine/DTI, and SDS/DTI extracts of GBM and 
TBM were electrophoresed on 6% vertical polyacrylamide slab gels in the 
presence of a reducing agent Positions of molecular weight markers are shown to 
the left. 
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Figure 111.6 Laminin in GBM and TBM extracts. Guanidine (Gu), 
guanidine/DTf, and SDSIDTT extracts were electrophoresed as in Fig. 111.5; the 
immunoblot was reacted with anti-laminin antibodies. 
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Figure 111.7 Fibronectin in GBM and TBM extracts. Electrophoresis and 
transfer procedure are identical to that of Fig. ill.6 Immunoblot was reacted with 
anti-fibronectin antibodies. 
54 
c: > --... -
Gu 
c: (.) c: -- ~ ~ 
.5 ~ Gu/OTT SOS/OTT ~ 
E .c -





Figure III. 7 
Figure 111.8 EliSA measurement of laminin and fibronectin in mouse GBM and 
TBM. Laminin and fibronectin were quantitated in the guanidine and 
guanidine/DTT extracts of GBM and TBM. Bars indicate the total amounts of 
laminin and fibronectin measured while the solid areas reveal the amounts 
measured in the guanidine and the hatched areas reveal the amounts measured in 
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Figure III.S 
IV. DIFFERENTIAL EFFECTS OF EXPERIMENTAL DIABETES AND 




The hallmark of renal diseases involving the glomerulus is the presence of 
proteinuria. While the pathogenesis of proteinuria has not been established, alterations in 
the charge barrier as well as the size barrier of the glomerular basement membrane 
(GBM) have been implicated. We evaluated the acute effect of streptozotocin diabetes 
and passive Heymann nephritis (PHN) on the macromolecular composition of rat GBM 
to detennine if changes in composition correlate with proteinuria in these two models of 
kidney disease. Six to twelve rats from each group (control, diabetic, and PHN) were 
killed 1, 5, 28, 56, 84 days after administration of injections. Identical amounts of GBM 
were subjected to a sequential extraction procedure and type IV collagen, entactin, 
laminin., fibronectin., and anionic charge content were quantitated in the extracts. 
ANOV A for type IV collagen content revealed no effects of time or disease; type IV 
collagen content averaged 29.1+1.2 Jig/mg dry GBM (Average of values from control, 
diabetic, and PHN at all five time points). Entactin also did not change., and averaged 
7.7±O.5% of type N collagen content. Both laminin and fibronectin contents increased 
with time in GBM, including control, and this increase was significantly greater in 
diabetic GBM. Detectable at day 28, a significant decrease in anionic charge content of 
diabetic GBM coincided with the onset of proteinuria. In PHN, no differences in type IV 
collagen, entactin, laminin., fibronectin or anionic charge content of GBM were found 
compared with control even though profound proteinuria was evident in PHN from day 5 
on. In diabetic rats, the increase in laminin content over control pr~ceded the onset of 
proteinuria, while the increase in fibronectin was not apparent until after proteinuria had 
begun. Although the changes in diabetic GBM glycoprotein content did not correlate 
directly with the presence or absence of proteinuria, the decrease in anionic charge 
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content did. Thus, control GBM was found to change its laminin and fibronectin content 
with age, while type IV collagen content and anionic charge remained constant. In 
diabetic GBM, an increase in laminin content and decrease in anionic charge are both 
candidates for alterations that could lead to proteinuria. In contrast, PHN resulted in 
profound proteinuria with no changes in GBM content. Thus, while GBM alterations 
may be important for development of proteinuria in streptozotocin diabetes, such changes 
are not involved in PHN. 
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INTRODUCTION 
In insulin dependent diabetes mellitus, loss of selective permeability with proteinuria 
constitutes one of the major characteristics of diabetic nephropathy. It is believed that 
progressive accumulation of glomerular extracellular matrix, both glomerular basement 
membrane and mesangial matrix, is an important "aspect of the defect that leads to 
proteinuria and ultimately to glomerular sclerosis with loss of functioning filtration units 
[59]. It is commonly assumed that morphological and functional alterations of the 
glomerular basement membrane in human and experimentally induced diabetes must be 
accompanied by changes in their macromolecular composition and structure [67]. While 
the pathogenesis of proteinuria has not been established, alterations in the charge as well 
as the size barrier of the glomerular basement membrane have been implicated as playing 
an intimate role in increased permeability [95]. Type IV collagen, laminin and 
fibronectin content were altered during different stages of diabetes [96]; however, very 
little is known about the content of these specific macromolecules during the acute stage 
of diabetes with respect to the onset of proteinuria. 
Similarly, passive Heymann nephritis, an animal model that closely resembles 
human membranous glomerulonephritis, displays thickened glomerular basement 
membrane, marked mesangial expansion and severe proteinuria [78]. PHN is 
immunologically induced by administration of a single injection of anti-FxlA antibody. 
This antibody is directed against rat tubular brush border and cross-reacts with an antigen 
on the surface of glomerular epithelial cells [79]. As a result, subepithelial immune 
deposits form and within one week severe proteinuria occurs followed by progressive 
GBM thickening and mesangial expansion [13]. 
Thus, in diabetes mellitus and passive Heymann nephritis, damage to the glomerular 
barrier occurs and is accompanied by an increase in penneability to proteins the size of 
albumin and larger. The present study was designed to detennine if any changes in the 
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macromolecular composition of glomerular basement membranes occur in these two 




Experimental animals. 162 age-matched male Sprague Dawley rats (Harlan Sprague 
Dawley, Inc., Indianapolis, Indiana), weighing 217+1g were divided randomly into three 
groups. Diabetes was induced in the fIrst group by a single intravenous injection of 
streptozotocin (60 mg/kg body weight in sodium citrate buffer, pH 4). Passive Heymann 
nephritis was induced in the second group by a single intraperitoneal injection of anti-
FxlA antibody. The third group of 54 rats served as the controls, receiving a single 
intraperitoneal injection of saline. For each of the three groups, rats were killed at the 
following times' post-injection: 1 day (n = 12); 5 days (n = 6); 28 days (n = 12); 56 days 
(n = 10-12); and 84 days (n = 9-12). The following physiologic measurements were 
made prior to death: body weight; serum glucose using a glucose analyzer 2 (Beckman, 
Palo Alto, California); and 24-hour urinary albumin using an inhibitory ELISA. Serum 
glucose levels were measured in the diabetic rats weekly_ To maintain these l~vels 
between 500 and 600 mgldl, all diabetic rats with levels greater than 450 mg/dl received a 
daily low-dose subcutaneous injection of 0.1 unit Lente insulin (Eli Lilly and Co., 
Indianapolis, Indiana). All animals were housed in the same room, received the same 
standard chow and bad free access to water. Rats were anesthetized with sodium 
pentobarbital prior to removal of kidneys and then killed by celVical dislocation. 
Renal histology. Kidneys from control, diabetic and PHN rats at one and three 
months were used for histology_ Immediately after removal of kidneys, thin coronal 
sections were made. These sections were immersion-fixed for two hours in Bouin's 
solution, transferred into 70% ethanol, embedded in paraffin, sectioned and stained with 
silver [97]. 
Isolation and extraction of glomerular basement membrane. All isolation and 
extraction procedures were at 0-4°C in the presence of the following protease inhibitors: 
ImM pbenylmethylsulfonyl fluoride, ImM EDTA, lJ..lg/ml aprotinin, IJ..lg/mlleupeptin, 
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and IJ..lg/ml pepstatin. At each time point, the rats within each of the three groups were 
divided into two groups and batch processed. Kidneys were excised, decapsulated and 
the cortex was cut away .. Glomeruli were separated from cortices using standard sieving 
procedures [98] (Fig. IV.l). Briefly, tissue was minced, then forced through a #170 
stainless steel sieve, pore size 9OJ.lm, while being rinsed frequently with chilled PBS 
solution. Lastly, the sievings were poured onto sequential sieves of 180, 150, 75, and 63 
Jlm pore sizes with the glomeruli collecting on the 75 and 63 J,lffi sieves. When viewed, 
the glomerular fraction contained a mixture of capsulated and decapsulated glomeruli 
with less than 5% contamination by small tubular fragments (Fig .. N.2). 
Glomeruli were resuspended separately in PBS containing 1 % sodium deoxycholate 
at a volume of lmU50mg tissue wet weight. Samples were sonicated at 20 watts for 
lmin/3ml volume using a Cole-Panner model 4710 ultrasonic homogenizer with a 2mm 
probe. The sonications were performed stepwise for 1 minute followed by I minute of 
cooling, with the sample tube always on ice. After sonication the samples were 
centrifuged at 48,OOOg for 30 minutes. The sonication procedure was carried out two 
more times, and the resulting basement membrane pellets were transferred to 1.Sml 
centrifuge tubes, washed three times with water, and repelleted each time at 16,OOOg. 
The final GBM pellets were lyophilized and weighed. 
Glomerular basement membrane was subjected to sequential extractions according to 
a procedure modified from that of Mohan and Spiro [15] (Fig. IV.I). Purified GBM 
(2mg) was suspended in Iml 5M guanidine hydrochloride, sonicated for I minute at 20 
watts and extracted for three hours at room temperature on an end-over-end rocker. 
Samples were centrifuged at 16,OOOg for 20min, and the supernatants decanted. The 
pellets were resuspended in 0.5ml of SM guanidine with 0.02M dithiothreitol 
(guanidinelDTT), and kept at room temperature for three hours on an end-over-end 
rocker, and centrifuged. Finally, the pellets were resuspended in O.Sml of 2% SDS, 
O.02M DTT, and incubated for 1 hour at 100°C. After cooling, the samples were 
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centrifuged at 16,OOOg for 20min, and the SDSID1T extract was decanted leaving small, 
insoluble pellets. 
Analysis of extracts. Total protein of the three extracts was measured using a micro 
bicinchoninic acid assay (Pierce) with bovine serum albumin as the standard. Aliquots of 
the guanidine and guanidine/D1T extracts were dialyzed for 72 hours against 3M urea to 
remove guanidine and DTf, which was shown to interfere with the micro BCA assay. 
Aliquots of the SDSIDTf extracts were dialyzed for 72 hours against PBS at room 
temperature to remove the DTf and most of the SDS. 
SDS polyacrylamide gel electrophoresis was performed using vertical slab gels [89]. 
Samples were electrophoresed on 6% gels with an overlying 4% stacking gel. Proteins 
were visualized by silver or transferred to a nitrocellulose membrane (Schleicher & 
Schuell Inc., Keene, New Hampshire) and immunoblot analysis was performed [90]. 
Type IV collagen, laminin, fibronectin and entactin were quantitated using inhibitory 
ELISA's [91]. Briefly, 96-well microtiter plates (plate #3590, Costar Corp., Cambridge, 
Massachusetts) were coated with antigen. Specific antibody was incubated overnight 
with known quantities of the antigen or dilutions of unknown samples. The wells were 
rinsed, then anti-IgG conjugated to horseradish peroxidase was added. Bound antibody 
was detected colorimetrically using 2-2 azino-di-(3ethyl benzothiazolin). Amounts of 
type IV collagen, laminin, fibronectin and entactin were calculated from standard curves 
using AssayZap 2.0 (BIOSOFf, Ferguson, Missouri). 
Anionic charge content of the GBM was quantitated from scanned images of dot 
blots stained with alcian blue [99]. Known amounts of heparan sulfate (Sigma Chemical 
Co., St Louis, Missouri) and samples from the 5M guanidine extracts were reacted with 
Immobilon-N membrane (pore size: O.45J.lm; Millipore Corp., Bedford, MA) in a dot-
blot apparatus for 15 minutes. Another identical group of known and unknown samples 
were treated with nitrous acid for 15 minutes on ice prior to reacting with membrane. 
Following a brief rinse with PBS under vacuum, the membrane was removed from the 
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apparatus and allowed to soak for 30 minutes in PBS containing 0.5% tween 20, pH 7.4. 
The membrane was then stained for 20 minutes with ~e following: 0.2% alcian blue, 
O.05M Na acetate, 0.05 M MgCI2, and O.05M NaCI, pH 5.7. After drying, the membrane 
was digitized using a flatbed scanner (HSD Scan-X, HSD) and a Macintosh IIfx 
computer. Densitometric analysis was performed using Image 1.41 program (NIH, 
Bethesda, Maryland). 
Source of antigens & antibodies. Rat serum albumin (used for albumin ELISA) was 
from Sigma Chemical Co. (St Louis, Missouri). Polyclonal antibodies to rat serum 
albumin were generated in rabbits using rat serum albumin (Sigma Chemical Co., St 
Louis, Missouri). Polyclonal antibodies to type IV collagen were the generous gift of Dr. 
Kevin McCarthy, University of Alabama (Binningham, Alabama). Polyclonal antibodies 
to laminin were the generous gift of Dr. Dale A. Abrahamson, University of Alabama 
(Birmingham, Alabama). Fibronectin and anti-fibronectin were from Telios 
Pharmaceuticals (San Diego, California). Entactin and anti-entactin were from Upstate 
Biotechnology, Inc. (Lake Placid, New York). The anti-rabbit IgG was from Pierce 
(Rockford, Illinois). Specificity of these antibodies were tested using inhibitory ELISA 
as shown in figure IV .14. 
Statistical Analysis. Comparisons among the different groups at each time point 
and over the course of the study were made by analysis of variance using the Tukey-
Kramer HSD test The statistical analyses were conducted using JMP 2.0 (SAS Institute 
Inc., Cary, NC) and significance was assigned at the P < 0.05 level. 
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RESULTS 
Experimental animals. Mean values from rats killed 1, 5, 28, 56, and 84 days after 
injection for body weight, serum glucose, kidney weight to body weight ratio, and dry 
GBM weights are summarized in Table IV.I. At the time of injection, the body weights 
of the control, diabetic and PHN rats were not different (control = 218.9±I.3g; diabetic = 
216.8+1.3g; PHN = 216.4+I.3g). Weight gain in the diabetic and PHN rats was less than 
that of control rats from day 28 through day 84; however, the reduced rate of weight gain 
was exacerbated in the diabetic rats. Twenty-four hours after injection of streptozotocin, 
serum glucose levels were elevated significantly as compared to control and PHN rats. 
These levels continued to increase and then stabilized between 500-600 mg/dl with the 
low-dose insulin therapy throughout the study. All of the stretozotocin injected rats for 
the 28, 56, and 84 day time points received daily low dose injections of insulin. Wet 
kidney weights corrected for body weight were significantly greater in both the diabetic 
and PHN versus control rats from day 5 through day 84. There was a significant increase 
in the ratio of dry OBM to wet weight cortex with time, while disease had no effect on 
this ratio. 
Silver-stained histological preparations of control, diabetic and PHN rat kidneys 
from one month (Fig. IV.3) and three months (Fig. IV.4) demonstrated no striking 
morphological differences among the control, diabetic and PHN rats or between the two 
time points. The physiological measurements for these rats are in Table N.2. Because 
only one rat from each group was used, no statistical tests were executed; however, the 
increased serum glucose for the one and three month diabetic rats over control rats can be 
appreciated. Profound increases in urinary albumin excretion rate were seen in the one 
and three month PHN rats. The diabetic rats at one and three months showed urinary 
albumin excretion rates that were elevated over age-matched control rats. 
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Values for sequential determinations of urinary albumin excretion rate for each 
group are illustrated in figure IV.5. There was no difference in albuminuria on day one 
among the three groups. By day five overt proteinuria had developed in rats with passive 
Heymann nephritis, but there was no significant change in albuminuria in the control or 
diabetic groups. By day 28 there was a further significant increase in urinary albumin 
excretion to 575 mglday in the PHN group and urinary albumin excretion rate remained 
in this range on day 56 and day 84. Albuminuria was significantly increased in both the 
control and~ diabetic groups by day 28, but was significantly greater in the diabetic group 
than in the control group. There was a further increase in albuminuria in the diabetic 
group between day 28 and 56, but urinary albumin excretion rate remained constant 
between days 56 and 84. In contrast, there was no further change in urinary albumin 
excretion between days 28 and 56 or days 56 and 84 in the control group. 
Analysis of extracts. The distribution of total extracted GBM protein from control, 
diabetic, and PHN rats is shown in Figure IV.6. Neither time nor type of extraction 
affected the amount of protein extracted among the control, diabetic and PHN groups. 
However, within each of these groups the amount of protein extracted significantly 
decreased with subsequent extractions: guanidine extracted the greatest amount 
(J.l=425f..lg/mg GBM) and SDSIDTf extracted the least (J.l=270J.Lglmg GBM). 
Electrophoresis of GBM extracts revealed complex electrophoretic protein protiles 
among the guanidine, OTf, and SOSlDlT extracts. Silver staining of the guanidine 
extracts revealed numerous bands ranging from 220 kD down to 45 kD (the dye front) 
(Fig .. IV.7). Among these bands were some faintly detectable bands that migrated 
alongside laminin B chains, fibronectin and entactin. No obvious differences in staining 
of these were detected with time or between control, diabetic and PHN rats. A strong-
staining band at 90 kO in all three groups migrated alongside a fragment of the cellular 
fonn of fibronectin. Furthennore, all three groups revealed a strong staining band at 100 
kD that migrated alongside a fragment of entactin.. The presence of these low molecular 
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weight bands suggest that proteolysis of fibronectin and entactin occurred in the presence 
of protease inhibitors. 
Figure IV.S shows the guanidine/DTf extracts that revealed numerous bands whose 
range extended that of the guanidine to include bands up to 400 kD. Two very intensely 
stained bands~ one at 190 and the other at 210 kD~ were observed in all three groups. The 
210 kD band migrated alongside the laminin B chains and the 190 kD band migrated 
alongside a large fragment of fibronectin. A doublet at 400 - 440 kD was observed in all 
three groups. These two bands corresponded to the migration of laminin A chain (400 
kD) and dimeric fibronectin (440 kD). Several strong staining small molecular weight 
bands, specifically 45, 55 and SO kD were detected in control, diabetic and PHN samples. 
However, the intensity of staining was different among the three groups at each time 
point. PHN showed the strongest staining and diabetic showed the weakest for these 
three bands .. 
Figure IV.9 shows that the SDSIDTT extracts revealed essentially only high 
molecular weight bands that ranged from 350 down to 120 kD. Among these were two 
bands that migrated alongside the two alpha chains of type IV collagen, while a band at 
350 kD migrated alongside a band in the type IV collagen standard lane. This 350 kD 
may reflect oligomeric fonns of type IV collagen. 
Immunoblot analysis revealed that among these complex mixtures of proteins, type 
IV collagen was solubilized exclusively in the guanidinelDTT and SDS/DTf extracts 
while the glycoproteins, namely laminin, fibronectin and entactin were solubilized 
completely in the guanidine and DTT extracts. Figure IV.I0 shows immunoblots probed 
with type IV collagen antibodies from the five time points. Compared to the 
guanidine/DTT extracts, the SDSIDTf extracts revealed stronger staining at each of the 
five time points. This suggested that a greater amount of type IV collagen was extracted 
with SDS/DTT. No striking differences in staining were detected with time or between 
the control, diabetic and PHN rats. In addition to the alpha chains and oligomeric fonns 
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of type IV collagen, there were numerous small molecular weight bands that stained. 
These bands were presumably fragments of type IV collagen as indicated from staining 
with anti-collagen IV antibodys in immunoblots. 
Figure IV.II shows immunoblots of extracts from control, diabetic, and PHN GBM's 
probed with laminin antibodies. Only very faint staining was detectable for laminin B 
chains in the guanidine extracts. Similarly, the silver-stained gels revealed very faint-
staining of bands at 200 - 220 kD that corresponded to laminin B chains. The 
guanidinelDTf extracts reveal exclusive staining for the laminin B chains. These results 
suggested that the laminin A chain was not present or present but below the detection 
limit of the assay. 
Figure IV.12 shows immunoblots of extracts from control, diabetic, and PHN GBM's 
probed with fibronectin antibodies. No staining for monomeric fibronectin (220 kD) in 
the guanidine extracts was detected; however, several small molecular weight bands 
were stained and one of these bands stained very prominently, 100 kD. Thus, the lack of 
monomeric fibronectin in the presence of immunoreactive fragments suggested that 
proteolysis of this protein occurred during its extraction with guanidine. The 
guanidine/DTf extracts revealed strong staining at 220 kD that corresponded with the 
monomeric fonn of fibronectin, and a few large fragments of fibronectin in all three 
groups at each time point 
Figure IV. 13 shows immunoblots of extracts from control, diabetic, and PHN·GBM's 
probed with entactin antibodies. The guanidine extracts at days 1, 5, 28 and 56 revealed a 
doublet at 90 leD with the lack of staining for entactin at 150 kD. However, day 84 
revealed staining of bands at 150, 100 and 90 kD. The band at 150 kD stained very 
faintly while the 100 kD band stained more strongly. This 100 kD band, as described 
above, corresponded to an entactin fragment in the silver stained gels. Furthennore, a 
100 kD band that corresponded with the entactin fragment was stained in the laminin 
standard lane.. This band has been shown to be a breakdown product of EHS 
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entactin/nidogen, which is highly susceptible to proteolysis (Dr. Roy C. Ogle, personal 
communication). Thus, these results suggest that proteolysis of entactin occurred during 
its isolation with guanidine. The guanidine/DlT extracts revealed strong staining of 
entactin at 150 kD with some staining of fragments. No striking differences were 
observed for entactin with time or between the control, diabetic and PHN rats. 
The amount of type IV collagen was measured in both the guanidinelDlT and 
SDSlDlT extracts as shown in figure IV.I5. SDS/DlT extracted 50% more type IV 
collagen than that extracted with guanidine/DTf. The total amount of type IV collagen 
did not change as a function of time or disease as determined by ANOV A; type IV 
collagen content averaged 29.1+1.2 J..lg/mg dry GBM. Even though no significant 
differences were measured for type IV collagen, there was some variability in the 
measured amounts between control, diabetic, and PHN GBM. This variability may 
reflect small differences in weighing out the 2 mg of lyophilized GBM before extractions. 
Therefore, to take into account any differences in weight of GBM starting material, the 
measured amounts of the glycoproteins laminin, fibronectin and entactin were normalized 
to type IV collagen .. 
Laminin measured in the combined guanidine and DlT extracts increased with time 
in all groups: control, 4.6±O.2 to 8.2±O.1 J,.lg/mg dry GBM (days 1 to 84); diabetic, 
3.5±O.2 to 12.0±0.07 J.1g/mg; PHN, 3.6±O.05 to 10.5±O.3 J,1g/mg. However, the increase 
in laminin was greater in magnitude for the diabetic GBM as compared to control and 
PHN starting on day 5 (Fig. N.16). Although the fIrst measurable increase in laminin in 
diabetic GBM occurred prior to the onset of proteinuria (day 28; Fig. IV.5), the greatest 
increase occurred between days 28 and 56, just after proteinuria was observed. By day 
84, the increased laminin content appeared to have peaked, paralleling the plateau 
observed for proteinuria. The measured amount of laminin in the PHN GBM revealed no 
significant differences compared to control GBM at any time point. 
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Fibronectin measured in the combined guanidine and DTT extracts of diabetic GBM 
showed a significant increase at day 56, coinciding with the dramatic increase in laminin 
but occurring after the establishment of proteinuria (Fig. IV.17). The fibronectin content 
continued to increase and exceeded the amount of type IV collagen (by 6±3%) by day 84 
(fibronectin conten~ days 1 vs 84 = 4.3±O.09 to 30.0±0.4 J,1g/mg dry GBM). The 
measured amount of fibronectin in the PHN GBM revealed no significant differences 
compared to control GBM at any time point (days 1 to 84, control = 7.2±O.3 to 9.0±0.1 
flg/mg dry GBM, PUN = 7.2±0.4 to 8.8±O.2 J.lg/mg). 
Entactin measured in the combined guanidine and DTT extracts did not change as a 
function of time or disease (Fig. IV.I8). The entactin content averaged 1.1±O.06 Jlg/mg 
dryGBM. 
Anionic charge content of the GBM was estimated by densitometric analysis of dot 
blots stained with alcian blue as illustrated by a typical blot in Figure IV.19. Alcian blue 
staining was significantly decreased in diabetic GBM as compared to control and PUN. 
This decrease was evident by day 28 and correlated with the onset of proteinuria in 
diabetic rats. Alcian blue staining remained significantly diminished throughout the time 
course for the diabetic GBM. Alcian blue staining of extracts from PHN glomeruli did 
not differ with time or from control GBM. 
Figure IV.20 shows a densitometric analysis of nitrous acid treated samples prior to 
staining blots with alcian blue. The nitrous acid treatment selectively degrades heparan 
sulfate glycosaminoglycan chains. Nitrous acid pretreatment showed decreased alcian 
blue staining that was not different between control, diabetic and PHN GBMs at days 1 
and 5. Alcian blue staining was greatly reduced in both control and PHN GBMs from 
day 28 on whereas the reduced staining in diabetic GBM was less dramatic. 
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DISCUSSION 
We compared the acute stages of diabetes and passive Heymann nephritis regarding 
proteinuria and changes in GBM macromolecular composition namely, type IV collagen, 
laminin, fibronectin, entactin and anionic charge content. Results showed profound 
alterations in GBM composition during the course of diabetes, however, no changes were 
detected in GBM macromolecular composition during the course of PHN. 
A characteristic feature of insulin dependent diabetes mellitus is thickened GBM. It 
has been suggested that an increased synthesis and accumulation of type IV collagen, 
laminin and fibronectin are responsible for the thickening [64,96]. However, these 
studies have not precisely defined when increases occurred in relation to the onset of 
proteinuria in diabetes. The streptozotocin-injected rats displayed metabolic changes 
related to diabetes, namely severe hyperglycemia, polyuria, proteinuria and significant 
reduction in growth rate. However, morphologically no differences were noted at one or 
three months in the diabetic glomeruli versus control glomeruli. Morphological 
alterations in diabetic GBM were detectable by eight to twelve months using electron 
microscopy [100]. Therefore, our findings with light microscopy are consistent with the 
view that marked thickening of the GBM is not apparent in the early stages of diabetes in 
this model. 
In the present study, the acute stages of diabetes had no effect on type IV collagen 
content. It is generally accepted that type IV collagen is increased in human diabetic 
GBM [11]. However, this belief reflects long-te~ effects of diabetes on glomeruli from 
both human and experimental animals. In contrast, acute studies revealed a delayed 
induction of type IV collagen synthesis in models of diabetes. Ledbetter et al [101] 
measured the mRNA levels of the classical chains of type IV collagen [al(IV), a2(IV)] 
in the cortices of spontaneously diabetic KKAy mice; mRNA levels were unchanged 
after one and two months with a two-fold increase detectable at four months. In addition, 
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Ihm et al [102] using isolated glomeruli from streptozotocin diabetic rats detected no 
changes in glomerular al(IV) mRNA levels at one week or one month. Collectively, 
these data indicate a lack of change in the amount of type IV collagen during the onset of 
experimental diabetes, thus suggesting a delayed induction of type IV collagen synthesis. 
It is unclear if proteinuria has any effect on this increased type IV collagen production. 
It has been shown that diabetic GBM becomes less soluble with disease progress. 
Specifically type IV collagen was more resistant to proteolysis and extraction techniques 
[103,104]. Our results showed that no differences were apparent in the amounts of total 
protein extracted from control, diabetic and PHN GBM. Although SOS-PAGE revealed 
complex protein profiles among the guanidine, 017, and SOS extracts, there were no 
striking differences in these profiles between control, diabetic and PHN extracted GBM. 
Furthermore, there were no differences among these electrophoretic protein profiles with 
time. Collectively, these results suggest that the lack of differences in type IV collagen 
content were not due to proteolysis or decreased solubility of GBM or collagen. 
Other studies of laminin content in human diabetic GBM have revealed a differential 
expression during the disease: Early and intermediate stages showed increased 
immunostaining for laminin with a diminution in this staining during the late severe 
stages [96,105]. The results presented here and in conjunction with those of Spiro and 
coworkers are consistent with a differential expression of laminin content during 
diabetes. Our findings demonstrated a 35 % increase in laminin content during the acute 
stages while Spiro and coworkers showed a 40% decrease in late severe stages of human 
diabetes. In addition, cultured mesangial cells grown in high glucose concentration after 
one week, revealed a 40 - 50 % increase in laminin Bl chain mRNA with a subsequent 
50 % increase in secreted laminin after one month [106]. Thus, the results described 
herein suggest that hyperglycemia affects the synthesis of laminin during the acute stages 
of diabetes. Although the increased laminin content was initially detectable at day 5, a 
more pronounced increase occurred during the interval immediately following 
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proteinuria. Taken together, these results suggest that proteinuria exacerbates the 
hyperglycemic-induced increase in laminin. Interestingly, the control GBM displayed 
increased laminin content on days 56 and 84 that was significantly greater than days 1, 5 
or 28. Prior to this increase in laminin content, the control rats displayed proteinuria, 
although not as significant as the diabetics. Thus, perhaps laminin is involved in the 
progression of proteinuria. 
Data for fibronectin content in human and experimental diabetes are conflicting. 
Some studies revealed no changes in amount of fibronectin in late severe stages [12], 
while others reported significant increases after six weeks [107]. Furthermore~ mesangial 
cells grown in high glucose concentration revealed increased fibronectin secretion and 
mRNA levels after one week, suggesting hyperglycemia has a direct effect on fibronectin 
production [106]. Our findings revealed a profound increase in fibronectin content 
during the interval immediately following proteinuria. Collectively, these contradictory 
fmdings suggest that altered fibronectin production increases after the onset of proteinuria 
with subsequent decreases in the late severe stages of the disease. This suggests a 
similarly altered differential expression during the progression of diabetes as suggested 
for laminin. The concomitant massive increases in laminin and fibronectin during the 
interval immediately following proteinuria might be a result of a compensatory 
mechanism to restore normal filtration. 
Similar to type IV collagen, diabetes had no effect on entactin/nidogen content. 
Examination of entactin/nidogen in diabetic kidneys was, until now, limited to 
immunostaining. Immunohistochemical studies revealed in early stages of diabetes 
prominent entactin/nidogen staining in mesangium where mesangial expansion was 
present [108]. This mesangial staining disappeared with progression of the disease; 
however, thickened GBM showed an increased entactin/nidogen staining. Amounts of 
entactin/nidogen have not been measured in diabetic GBM. In the acute assessment of 
GBM composition described herein, quantitation of entactin/nidogen revealed no effects 
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of disease or time. Thus, in conjunction with immunohistochemical studies, 
entactin/nidogen does not appear to be altered during acute stages, but may be affected 
with progression of diabetes. 
The physiological relevance of type IV collagen, laminin, fibronectin, and entactin in 
the glomerular barrier is unknown. However, the functional significance of the anionic 
charge barrier with the normal filtration properties of the GBM has been demonstrated. 
Kanwar showed that a reduction in one of the anionic constituents of GBM, heparan 
sulfate, resulted in altered charge permselectivity of the GBM with subsequent 
proteinuria [65]. It is commonly accepted that the content of heparan sulfate 
glycosaminoglycan chains and heparan sulfate proteoglycans are diminished in the early 
stages of diabetes. Additionally, selective degradation of heparan sulfate 
glycosaminoglycan chains did not greatly decrease the alcian blue staining; however, 
nitrous acid pretreatment revealed marked decreased staining for control GBM samples. 
In the diabetic GBM, this suggested that the remaining alcian blue staining represents 
more components that contribute to the charge barrier, but heparan sulfate is specifically 
important for the filtration barrier. Thus, our finding of marked decreased anionic charge 
content is consistent with findings in human and experimental diabetes. Furthermore, the 
decreased GBM anionic charge content with concomitant proteinuria supports the 
intimate association between the charge barrier and retention of plasma proteins. 
In contrast to diabetes, passive Heymann nephritis resulted in rapid and severe 
proteinuria five days after injection of anti-FxlA antibody. Proteinuria peaked at one 
month and persisted throughout the study. Considering this severe functional change, no 
gross morphological alterations were noted in glomeruli from PHN rats after one month. 
However, some capillary dilation and thickened GBM were evident after three months of 
disease. Quantitation of type IV collagen, laminin, fibronectin, entactin, and anionic 
charge content are scarce but consistent. The results presented here revealed profound 
proteinuria at day five but no measurable changes were detected in type IV collagen, 
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laminin, fibronectin, entactin, and anionic charge content in the GBM_of PHN rats during 
the acute stages of this disease. 
Similarly, Floege et al [109] revealed no changes in these macromolecules with 
PHN. It was shown that rats displayed marked proteinuria by day five, with no 
significant alterations in glomerular morphology or GBM expansion seen during the 
fifteen day period. Furthennore, gene expressions of type IV collagen, laminin B2 chain, 
and S-laminin were examined and the mRNA levels for these components were 
unchanged during the fifteen day study. Thus, it was concluded that the mechanisms that 
lead to thickened GBM were probably different from the complement-induced 
proteinuria. 
Recent studies on the intrinsic glomerular epithelial cell antigen with which the 
FxlA antibody cross reacts have revealed the involvement of integrin receptors. Adler 
and Chen [79] demonstrated that the FxlA antibody recognizes the a3~1 integrin, 
specifically the PI subunit. In studies with cultured rat glomerular epithelial cells, anti-
FxlA antibody inhibited growth, spreading, and adhesion to type IV collagen, laminin 
and fibronectin. Similar results were produced when using anti-PI antibody. Thus, it 
was postulated that antibodies to glomerular epithelial cell antigens interfered with the 
Donnal cell-GBM interaction resulting in epithelial cell effacement and retraction from 
the GBM [110]. Subsequently, the altered interaction of the epithelial cell and GBM in 
conjunction with the complement system resulted in proteinuria. 
In summary, it was shown conclusively that these two models of kidney disease are 
quite different. Diabetes affects the GBM macromolecular composition; a significant 
reduction in anionic charge content correlated with significant proteinuria and significant 
increases in both laminin and fibronectin that occurred in the period immediately 
following proteinuria. Therefore, it is likely that the decreased negative charge content 
resulted in proteinuria while the explosive increase in laminin and fibronectin were a 
compensatory result to patch the damaged glomerular barrier or a pathological responce 
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to proteinuria. Although overt proteinuria was evident after five day~, passive Heymann 
nephritis had no effect on the GBM macromolecular composition: no changes in type IV 
collagen, laminin, fibronectin, entactin or anionic charge content were detected. Thus, 
the stimuli that lead to changes in GBM composition in diabetes are likely related to 
those which result in proteinuria; however, there appears to be no relationship between 
the GBM composition and overt proteinuria in PHN, or between the mechanisms for the 
. induction of proteinuria in diabetes and PHN. 
Figure IV.I Method for the separation of rat glomeruli followed by isolation and 
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Figure IV.2 Digitized video images captured from bright field light microscopy of a 
suspension of rat glomeruli purified on 75 and 63Jlm sieves. A: Low magnification. B: 




Table IV.I Physiological parameters in control, diabetic and PHN rats measured 




Serum glucose, Kidney weight Dry GBM 
Day Injection N Body weight,g mg/dl g/xl00g body weight mg/g Cortex -
1 CONTROL 12 224.4+3.2 102.3+6.9 6.18+1.09 0.63+0.31 
DIABETIC 12 233.5+5.6 255.4+16.9 * 5.31+0.77 0.49+0.15 
PHN 12 208.0±3.3 79.3+4.1 6.79±0.13 0.52+0.19 
5 CONTROL 6 249.7+4.1 68.7+2.0 4.94+0.45 0.30+0.04 
DIABETIC 6 225.0±5.8 175.0±25.6 * 5.67+0.53 * 0.25+0.001 
PHN 6 234.8+4.0 73.5+10.4 5.86+0.50 * 0.28+0.001 
28 CONTROL 12 366.8+4.5 152.4+4.1 4.58+0.26 0.47+0.05 
DIABETIC 12 232.4+ 12.9 * 536.9+ 18.6 * 6.86+0.84 * 0.68+0.15 
PHN 12 319.8+ 11.8 * 149.2+5.2 6.11+0.66 * 0.63+0.08 
56 CONTROL 12 411.2+5.5 148.2±3.2 3.99±0.10 0.80+0.14 
DIABETIC 10 303.3+ 10.4 * 589.4+25.4 * 5.46+0.01 * 0.68+0.11 
PHN 10 387.6+9.9 184.2+10.6 4.47+0.27 * 0.40+0.14 
84 CONTROL 12 431.8+7.0 167.8+5.9 4.70±0.11 0.70+0.04 
DIABETIC 12 332.2+7.1 * 604.1+16.7 * 7.96+0.38 * 0.64+0.03 
PHN 9 399.8+4.1 * 191.3+11.6 5.00±0.34 * 1.23+0.19 
* p < 0.05 vs control group 
Figure IV.3 Histological preparations of (A) control, (B) diabetic and (C) PHN 
rat kidneys one month after injections. Tissue sections were stained with silver. 
No morphological differences were apparent among the three treatments: silver 
staining revealed unifonnly thin GBM and minor amounts mesangial matrix. C, 
capillary lumen. 
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Figure IV.4 Histological preparations of (A) control, (B) diabetic, and (C) PHN 
rat kidneys three months after injections. Tissue sections were stained with silver. 
No gross morphological differences were apparent between control and diabetic 
glomeruli. Overall, silver staining revealed uniformly thin GBM and minor 
amounts mesangial matrix with one capillary loop in diabetic glomerulus that was 
dilated and possible thickened GBM. The PHN glomerulus revealed several 
dilated capillary loops and silver staining indicates randomly thickened GBM 
(arrowheads). Mesangial staining does not appear to be increased compared with 
control. C, capillary lumen. 
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. Table IV.2 Physiological parameters from control, diabetic and PHN rats 
measured prior to death in rats for sacrifice one and three months after injection. 
Ualb = urinary albumin excretion rate, n = 1. 
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Table IV.2 
Body weight Body weight Serum glucose, Ualb. 
Day Injection at injection,g at death,g mg/dl mg/day 
28 Saline 196 315 178 2.9 
Diabetic 204 197 662 6.7 
PHN 220 336 129 503 
84 Saline 211 436 159 5.2 
Diabetic 223 335 592 15.9 
PHN 235 480 163 598 
Figure IV.S Urinary albumin excretion rate measured in control (open squares), 
diabetic (solid squares) or passive Heymann nephritis (pHN) (open circles) rats at 
1 to 84 days post-injection (6 - 12 rats per group, see table IV.!). Inserts are of 
normalized volumes of urine samples from 1 to 84 days that were electrophoresed 
on 10% gels and stained with silver. Immunoblotting analysis revealed that the 
bands stained with silver reacted with antibodies to rat serum albumin. The fITst 
detectable staining was at day 5 for the PHN rats. This staining corresponded with 
the increased urinary albumin excretion in the PHN rats. This staining in the PHN 
samples increased with time as did the urinary albumin excretion rate in these 
rats. Both the control and diabetic samples showed staining beginning at day 28 
that continued through day 84. The staining was greater for the diabetic versus 
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Figure IV.6 Distribution of protein in sequential extracts of GBM. GBM from 
control, diabetic and PHN rats were treated sequentially with 5M guanidine (solid 
bars), 5M guanidinellOmM OTI (hatched bars), and 2% SDS/DTI (stippled bars) 
as described in methods. The graph indicates for each treatment the pe~centage of 
protein extracted based on initial dry weight of basement membrane. Values are 
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Figure IV.6 
Figure IV.7 Silver stained gels of solubilized components of GBM from control, 
diabetic and PHN rats. Normalized quantities (about 2 ).1g/lane) of guanidine (Gu) 
extracts of GBM were electrophoresed on 6% vertical polyacrylamide slab gels in 
the presence of a reducing agent. Positions of molecular weight markers are 
shown to the left. 
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Figure IV.8 Silver stained gels of solubilized components of GBM from control, 
diabetic and PHN rats. Normalized quantities (about 2 J.1g/lane) of 
guanidine/DTT, extracts of GBM were electrophoresed on 6% vertical 




















































Figure IV.9 Silver stained gels of solubilized components of GBM from control, 
diabetic and PHN rats. Normalized quantities (about 2 Jlg/lane) of SDSIDTT 
extracts of GBM were electrophoresed on 6% vertical polyacrylamide slab gels in 
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Figure IV.IO Type IV collagen in GBM extractsfrom control, diabetic and PHN 
rats. The guanidine (Gu), guanidine/DTT, and SDSIDTT extracts were 
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Figure IV.II Laminin in GBM extracts from control, diabetic and PHN rats. 
The guanidine (Gu), guanidine/DTT, and SOS/OTT extracts were 
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Figure IV.U Fibronectin in OBM extracts from control, diabetic and PHN rats. 
The guanidine (Gu), guanidine/DTT, and SDS/DTT extracts were 
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Figure IV.14 A typical inhibitory EliSA (A) and testing reactivity of antibodies 
to type IV collagen, laminin, fibronectin and entactin on plates coated with 
laminin (B); fibronectin (C); and entactin (D). A: Typical inhibitory ELISA for 
type IV collagen. Plate coated with 400 ng type IV collagen/well. 1:1000 
dilution of type IV collagen antisera. This assay could detect between 1.7 to 
17ng/J,l1 EHS type IV collagen. Zero protein value represents maximal binding of 
antibody to antigen. B: Type IV collagen, fibronectin and entaetin showed no 
reactivity with anti-Iarninin antibodies. This assay could detect between 0.2 to 
1.7ng/JlI EHS laminin; C: Type IV collagen, laminin and entactin showed no 
reactivity with anti-fibronectin antibodies. This assay could detect between 20 to 
200pg/J,l1 rat plasma fibronectin; and D: Type IV collagen, laminin and 
fibronectin showed no reactivity with anti-entactin antibodies. This assay could 
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Figure IV.IS Type IV collagen measured in the combined guanidine/DTT and 
SDSIDTT extracts from control (open bars), diabetic (gray bars) and PHN (black 
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Figure IV.16 Laminin measured in the combined guanidine and orr extracts 
normalized to the measured amount of type IV collagen from control (open bars), 
diabetic (gray bars) and PHN (black bars) GBM. Values are means ± SEM, n = 8. 
* P < 0.05 versus control. 
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Figure IV.16 
Figure IV.17 Fibronectin measured in the combined guanidine and DTI extracts 
nonnalized to the measured amount of type IV collagen from control (open bars), 
diabetic (gray bars) and PHN (black bars) OBM. Values are means + SEM, n = 8. 




* 0 ... 
> 100 -I 
0 




N -- 40 -ca 
E 
'- 20 0 
Z 
0 a <). ,o~ c a. ,o~ c a. ,o~ Co <). ,o~ c a. '% 
~~~~ ~ o~~ ~~ ~ o,,~ ~6 ~ o"6! ~~ ~ o,,~ ~6 ~ 
0/ ~o 0/ ~o 0/ 196b 0/ ~b 0/ 19&, t' 
Day 1 Day 5 Day 28 Day 56 Day 84 
Figure IV.17 
Figure IV.IS Entactin measured in the combined guanidine and DTT extracts 
normalized to the measured amount of type IV collagen from control (open bars), 
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Figure IV.19 
Figure IV.20 Densitometric analysis of nitrous acid treated samples. Samples 
were pretreated with nitrous acid then blotted and stained as in figure IV.19. 
The bar graph reflects percentage of decreased aleian blue staining values 
assigned by the densitometric scanning process for control (open bars), diabetic 
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Studies involving isolated glomerular basement membrane date back to 1951 when 
Krakower and Greenspon localized a nephrotoxic antigen in dog kidneys [111]. Methods 
for isolating glomerular basement membrane essentially have involved detergent 
solubilization or ultrasonic homogenization. For the experiments in this dissertation, the 
isolation methods were modified by combining them. In addition, little infonnation has 
been obtained as to the purity of isolated glomerular and tubular basement membranes. 
In retrospect, it was necessary to detennine if any cellular components contaminated the 
isolated basement membranes and more importantly if any known basement membrane 
components have been solubilized in the detergent. Examination of the deoxycholate 
supernatants using SDS-PAGE revealed that the deoxycholate-soluble material was 
effectively removed from mouse glomerular and tubular basement membrane and from 
rat glomerular basement membrane. Immunoblot analysis indicated that type IV collagen 
and lanlinin were not lost from mouse or rat GBM; however, some fibronectin was lost 
during the isolation procedure. This loss is believed to represent loosely associated, 
plasma fibronectin and not integral GBM fl bronec tin , however, this was not tested . 
. Immunoblot analyses revealed that some type IV collagen, laminin and fibronectin were 
lost from TBM during its isolation. However, the immunostaining suggested that the 
losses were not significant. These results suggest that the modified isolation method for 
basement membrane used here yields pure preparations of GBM; however, more 
refinement of the sonication procedure is required for isolation of TBM. 
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INTRODUCTION 
Essentially three methodologies exist for the separation of glomeruli andlor tubules 
from kidneys and, within each of the methods, variations have been used. The first 
method dates back to 1951 when Krackower and Greenspon [Ill] separated glomeruli. 
This method involved using a series of sieves containing differential pore sizes to first 
disrupt the tissue then to trap glomeruli and/or tubules on different sieves. This is by far 
the most widely used and preferred method; however, it is extremely important to tffine-
tune" the sieve sizes to account for the differing sizes of glomeruli in various animals. 
This technique has been very successful for separating glomeruli and tubules from rat 
[112,113], dog [98,114], bovine [6,115], and human [116,117]. 
In 1958, Cook and Pickering [118] developed an elegant method to separate 
glomeruli from kidneys. This method involved perfusing kidneys with a suspension of 
iron oxide after which the kidneys were homogenized in a test-tube. Only the glomeruli 
trapped the iron particles, so that when a magnet was held up against the wall of the test-
tube, the tubule fragments could be poured off leaving behind an enriched glomerular 
fraction. This method has been used successfully on rats [119,120], rabbits [118,121] and 
very recently on mice [122,123]. 
The third method, using density gradient centrifugation, separates glomeruli and/or 
tubules based on different densities. Typically the kidneys are forced through a single 
sieve or homogenized to disrupt tissue prior to applying to either a discontinuous ficoll or 
sucrose gradient. Since frrst introduced by Grant et al [124], other investigators have 
used ficoll gradients for the separation of glomeruli from ra~ rabbit and human kidneys 
[125], the separation of tubules from rat and mouse kidneys [126-128], or the separation . 
of both glomeruli and tubules from human kidneys [129]. Successful separation of 
glomeruli and tubules has also been achieved using discontinuous sucrose gradients on 
mouse kidneys [88,130,131]. 
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To summarize, the most tried and tested method for the successful separation of 
glomeruli and tubules from rat kidneys has been sieve separation. The diameter of mouse 
glomeruli and tubules do not differ enough to make successful separations with sieving; 
however, separation of these mouse tissues has best been accomplished using sucrose 
gradient centrifugation. 
Subsequent isolation of basement membrane from the glomerular and tubular 
fractions has been performed using several methodologies. The common denominator 
among the methods is the use of detergents and/or ultrasonic homogenization. Spiro [6] 
first introduced the use of ultrasonic homogenization in combination with sieving to 
isolate GBM from bovine kidneys. Later, a nondisruptive method for the isolation of 
GBM and TBM was introduced by Meezan et al [132]. This method involved lysing of 
cells in distilled water followed by subsequent treatment with deoxycholate (an anionic 
detergent). Both of these methods, detergent and sonication, have been compared by two 
separate groups. In the tITst group, isolation of GBM from rabbit glomeruli using 
nonionic or anionic detergents was compared to isolation using sonication alone [130]. It 
was detennined that anionic detergents were more effective than nonionic in removing 
cellular material from the basement membrane, based on a lower phospholipid content in 
the anionic detergent isolated basement membrane. The conclusion was that both 
methods were comparable but detergent yielded a more intact basement membrane. The 
second group made a similar comparison of detergent-treated versus sonication-treated 
methods for the isolation of GBM [133]. They detennined that the methods were overall 
similar yet had some differences. Electrophoresis revealed similar heterogeneous 
polypeptide patterns between the two methods; however, detergent treatment yielded 
more enriched collagen-typical amino acids, while sonication treatment yielded higher 
concentrations of sulfated glycosaminoglycans. It was concluded that the two methods 
were comparable, yet warned that these methods would also result in the disruption or 
removal of certain constituents of the basement membrane. 
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In most of these studies described thus far, investigators were concerned about the 
purity of the isolated basement membrane. That is, they asked the question" had the 
cellular material been effectively removed during either detergent or sonication isolation 
of basement membrane? Both methods were shown to have effectively removed cellular 
contamination from the isolated basement membrane, as assessed by low levels of 
cellular markers such as DNA, RNA, and phospholipid phosphorous [6,130,133]. 
Although these isolation methods appear to be effective at removing cellular 
contamination, the specific loss of integral basement membrane components was never 
explored. In any compositjonal analysis of isolated basement membrane, it is imperative 
to know if loss of basement membrane components has occurred. In retrospect, we were 
curious as to the efficacy of our method for the isolation of GBM and TBM from mouse 
kidneys as well as GBM from rat kidneys. Specifically, were any known glomerular 
basement membrane components solubilized with the detergent? We assessed the purity 
of the isolated glomerular and tubular basement membranes using gel electrophoresis and 
immunoblots probing specifically for loss of collagen IV, laminin, fibronectin and 
entactin. 
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MATERIALS AND METHODS 
Isolation of mouse GBM and TBM. Mouse glomeruli and tubules were separated 
using sucrose gradient centrifugation followed by subsequent sonication of these tissues 
in the presence of deoxycholate to isolate GBM and TBM as described in chapter three. 
Isolation of rat GBM. Rat glomeruli were separated using differential sieving 
followed by subsequent sonication of this tissue in the presence of deoxycholate to isolate 
GBM as described in chapter four. 
Analysis of detergent supernatants. SDS polyacrylamide gel electrophoresis was 
perfonned using vertical slab gels [89]. Samples were electrophoresed on 6% gels with 
an overlying 4% stacking gel. Proteins were visualized by silver or transferred to a 
nitrocellulose membrane (Schleicher & Schuell) and immunoblot analysis was perfonned 
[90] as described in chapter three. 
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RESULTS 
Isolation of mouse GBM and TBM. Given that compositional differences were 
determined (chapter UI), it was important to determine if GBM and TBM had isolated 
similarly. To verify that removal of cellular material occurred without loss of basement 
membrane , samples of the consecutive deoxycholate supernatants from both glomeruli 
and tubules were run out on gels, and either stained with silver (Fig. V.I) or transferred to 
nitrocellulose and probed with anti-type IV collagen (Fig. V.2A) anti-Iaminin (Fig .. V.2B) 
and anti-fibronectin (Fig. V.2C). Figure V.l shows that most of the deoxycholate-soluble 
material was removed from the glomerular and tubular fractions with the frrst sonication, 
with only a few bands remaining in the third glomerular supernatant. However, in the 
tubules, the third deoxycholate supernatant showed an increase in solubilized material. 
Figure V.2A shows staining for type IV collagen in the third supernatant for tubules. 
The immunoblot of the deoxycholate supernatants probed with anti-Iaminin antibody 
(Fig. V.2B) showed no detectable staining in the supernatants from glomeruli; however, 
faint staining in the frrst and third supernatants from tubules was observed. Figure V.2C 
shows significant staining for fibronectin in all three deoxycholate supernatants from both 
glomeruli and tubules. 
Isolation of rat GBM. To assess differences in the diseased OBMs, it was necessary 
to determine if the two diseased GBMs isolated similarly .. To verify that removal of 
cellular material occurred, samples of the consecutive deoxycholate supernatants from 
glomeruli of control, diabetic and PHN rats were run out on gels and stained with silver 
(Fig. V.3). Figure V.3 shows that all the deoxycholate-soluble material was removed 
from the glomerular fractions of control, diabetic, and PHN rats by the fIrst sonication. 
As there were no differences in the staining patterns for these samples from days 1 to 84, 
figure V.3 is a representative silver-stained gel containing day 28 samples. To evaluate 
the loss of known GBM components during its isolation, samples of the consecutive 
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deoxycholate supernatants from glomeruli of control, diabetic and PHN rats were run out 
on gels, transferred to nitrocellulose and probed with anti-type IV collagen (Fig. V.4A) 
anti-Iaminin (Fig .. V.4B), anti-fibronectin (Fig. V .. 4C), and anti-entactin (Fig. V.4D). 
Each of these figures is a representative immunoblot containing samples from day 56. 
The immunoblots for type IV collagen, laminin and entactin revealed no staining for 
these macromolecules; however, the immunoblot for fibronectin revealed equally strong 
staining among the first and second deoxycholate supernatants from the glomeruli of 
control, diabetic, and PHN rats. 
131 
DISCUSSION 
Extensive preliminary tests separating mouse glomeruli and tubules using ficoll and 
percoll gradient centrifugation with prior disruption of tissue using various sieve sizes 
proved to be very unsatisfactory (data not shown). The method of using sucrose 
gradients proved to be very successful in separating pure fractions of glomeruli and 
tubules from the same mouse kidney; therefore, we chose to exploit this method [88]. 
The separation of glomeruli from rat kidneys is commonly performed using the 
differential sieving; therefore., we used this method for the separation of glomeruli from 
control, diabetic, and PHN rats. For the isolation of mouse GBM and TBM and rat 
GBM, we modified the detergent method of Meezan [132] and the sonication method of 
Spiro [6] resulting in a combination of the two. To our knowledge this is the frrst time 
sonication in the presence of deoxycholate has been used for the isolation of basement 
membrane.. Because of this it was necessary to evaluate the effects of volume of 
deoxycholate and length of sonication on equal weights of isolated glomeruli. We 
concluded that the volume of deoxycholate should be normalized to 1m! per 50mg wet 
tissue weight and that the sonication times also needed to be standardized to 1 minute per 
3ml deoxycholate volume. 
Isolation o/mouse GBM and TBM. For the present study, we assessed the purity of 
isolated mouse GBM and TBM using SDS-PAGE andimmunoblots probing specifically 
for loss of type IV collagen, laminin and fibronectin from the isolated basement 
membranes.. The results, based ... ·on electrophoretic profiles, demonstrated that the 
deoxycholate-soluble material was removed from the basement membranes. hnmunoblot 
analysis., however, showed that some type IV collagen and Iaminin were lost from TBM 
during sonication while some fibronectin was lost from both GBM and TBM. When pure 
tubular fractions were viewed by light microscopy, it was noted that a large number of 
tubule fragments were free of attached cells--exposed tubular basement membrane-
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whereas, glomerular fractions appeared to be intact structures with attached cells. Thus, 
the effects of the sonication treatments on the two tissue fractions may have been 
different, such that GBM was not initially as vulnerable to the sonication treatment as 
was TBM. The laminin lost during the isolation of TBM indicates that the difference in 
the amount of laminin (described in chapter three) would have been even greater between 
GBM and TBM. The difference in the amount of fibronectin we reported as compared to 
Mohan and Spiro [15] may be due to the loss of fibronectin during the modified isolation 
oftheGBM. 
Isolation of rat GBM.. Although the earlier results on the isolation of mouse GBM 
indicated that type IV collagen and laminin were not significantly lost during isolation, 
some fibronectin was lost during the deoxycholate and sonication procedures. Thus, it 
was necessary to detennine if GBM from control, diabetic and PHN rats had isolated 
similarly. The assessment of deoxycholate-sonication isolated rat glomerular baselnent 
membrane with type IV collagen, laminin and fibronectin was also extended to 
incorporate entactin. The results indicate that all the deoxycholate soluble material was 
removed from the GBMs. This is presumably an indicator of lack of cellular 
contamination. However, what this will not reveal is if some fragments of cytoskeletal 
elements or DNA are present in the isolated GBM. Type IV collagen, laminin and 
fibronectin were not lost from the GBM; however, some fibronectin was lost during the 
isolation procedure. The staining for fibronectin appeared to be of the same intensity 
among the control, diabetic and PHN GBMs. In addition, the staining was only detected 
in the fIrst and second deoxycho}.ate supernatant with the second supernatant revealing 
diminished staining. This suggests that this staining represented a more loosely 
associated or trapped fibronectin and that the fibronectin measured in GBM that required 
reducing conditions for extraction was of local origin. The deoxycholate-soluble 
fibronectin may actually represent serum fibronectin trapped during glomerular filtration, 
but this was not tested. 
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In summary, the modified method of basement membrane is<?lation used in this 
study yields pure preparations of GBM from both mice and rats. In the isolated TBM 
from mice, there is some loss of TBM components, although apparently not significant. 
These losses in TBM might be a result of greater vulnerability to sonication used in its 
isolation. The architectural geometry of glomeruli and tubules is quite different. The 
glomerulus is composed of highly coiled compact loops of capillaries that are ensheathed 
by the epithelial podocytes. The foot processes of the podocytes are highly interdigitated 
and anchored in numerous sites to the GBM through integrins. The endothelial and 
mesangial cells are also anchored to the GBM or mesangial matrix. Thus, this tightly 
associated arrangement of glomerular cell types results in a structure that may require 
thorough sonication. The tubule fraction is made up of different size fragments, however 
short, that are presumably open ended tubes. Each tubule fragment is composed of a 
single layer of epithelial cells anchored to the underlying TBM. In contrast to the GBM, 
the TBM has only one cell layer attached to it leaving the other side directly exposed to 
the first sonication. Thus, the tubular fraction may not have required as extensive 
sonication as the glomerular fraction. 
Figure V.I Assessment of the removal of deoxycholate-soluble protein from 
isolated mouse glomeruli and tubules by electrophoresis. Tissue was sonicated in 
the presence of 1 % deoxycholate and centrifuged; this was carried out a total of 
three times. Normalized volumes of the three subsequent deoxycholate 
supernatants from both glomeruli and tubules were electrophoresed, and then 
silver-stained. Lanes 1 to 3 illustrate consecutive 1 % deoxycholate supernatants 
from either glomeruli or tubules. Positions of molecular weight markers, 
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Figure V.2 Assessment of the removal of deoxycholate-soluble protein from 
isolated mouse glomeruli and tubules by immunoblotting. Nonnalized volumes of 
the three subsequent deoxycholate supernatants from both glomeruli and tubules 
were electrophorese<L transferred to nitrocellulose and immunoblotted with anti-
collagen IV (A), anti-Iaminin (B) and anti-fibronectin (C) antibodies. Lanes 1 to 
3 show consecutive 1 % deoxycholate supernatants from either glomeruli or 
tubules. elY, type IV collagen, lOflg; LM,laminin, Iflg; FN, fibronectin, IJlg. 
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Figure V.3 Assessment of the removal of deoxycholate-soluble protein from 
isolated rat glomeruli by electrophoresis. Normalized volumes of the three 
subsequent deoxycholate supe~atants from glomeruli were electrophoresed, and 
then silver-stained. Lanes 1 to 3 show consecutive 1 % deoxycholate supernatants 
from glomeruli of either control, diabetic or PHN rats. 
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Figure V.4 Assessment of the removal of deoxycholate-soluble protein from 
isolated rat glomeruli by immunoblotting. Normalized volumes of the three 
subsequent deoxycholate supernatants from glomeruli were electrophoresed, 
transferred to nitrocellulose and immunoblotted with anti-collagen IV (A), anti-
laminin (B), anti-fibronectin (C), and anti-entactin (D) antibodies. Lanes 1 to 3 
show consecutive 1 % deoxycholate supernatants from glomeruli of either control, 
diabetic or PHN rats. CIV, type IV collagen, l0J.1g; LM, laminin, IJ.1g; FN, 
fibronectin, IJ.1g; EN, entactin, IJlg. 
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A HETEROGENEITY OF GLOMERULAR AND TUBULAR BASEMENT 
MEMBRANES. 
Historically, the discovery of the EHS tumor (1980) was a turning point in 
elucidating the composition of extracellular matrices, specifically basement membranes. 
This tumor was shown to synthesize large amounts of basement membrane-like matrices 
and was readily grown in mass quantities in the hind legs of mice. Therefore, sufficient 
quantities of pure basement membrane were obtainable. Unlike native basement 
membrane, the EHS tumor was effectively solubilized using differential salt extractions. 
From these extracts, specific components were isolated and characterized using 
biochemical and immunological methods. Prior to the EHS tumor, studies on basement 
membrane composition were limited to chemical analyses. These analyses were 
conducted on glomerular basement membrane; however, the quantity of isolated GBM 
was limited and insoluble to conventional extraction procedures. Despite that specific 
constituents of basement membrane were not known, these chemical analyses were 
groundbreaking for proposing heterogeneity of basement membrane composition. 
Carbohydrate analyses revealed heterogeneity regarding sugar composition. It was 
concluded that GBM and TBM contained the same monosaccharides but differed in 
relative amounts: GBM contained a greater amount of sialic acid residues than TBM 
[134]. This suggested that the GBM contained a greater negative charge content than 
TBM. 
L,angeveld and coworkers made comparisons of glomerular and tubular basement 
membranes from different animals: cattle, pig, sheep, horse, and rat [135,136]. 
Conducted on the basis of amino acid composition, their studies detected differences in 
amounts of hydroxylated amino acids. This suggested heterogeneity of collagen content 
as hydroxylated amino acids are unique to collagen. These studies were extended to 
include comparisons of human glomerular and tubular basement membrane. It was 
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demonstrated that, regardless of age in men, the GBM contained more 3-hydroxyproline, 
mannose, and sialic acid residues than did the TBM [117,129,137]. 
In contrast, Butkowski and De demonstrated that the amino acid compositions of 
mouse GBM and TBM were very similar [131]. It was also demonstrated that the mouse 
OBM was similar to that of other species and that the chemical composition of mouse 
TBM was essentially identical to rabbit. Additionally, Brendel et al compared 
electrophoretic chromatographs of solubilized OBM and TBM from rabbits [121]. It was 
reported that there were no significant differences between the two basement membranes. 
As was demonstrated in chapter three, comparisons of electrophoretic 
chromatographs did reveal subtleties but not striking differences between mouse OBM 
and TBM despite the presence of significant quantitative differences in compositions. 
Thus, the results reported by Brendel et al were inconclusive [121]. The mouse kidneys 
used by Butkowski and De were from mixed strains and not age-matched. Because of the 
nonhomogeneous tissue donors, one cannot preclude that differences between mouse 
GBM and TBM may have been diluted. Furthermore, evidence exists for effects of age 
on basement membrane composition. The content of hydroxylated amino acids namely, 
lysine and proline, increased with age in normal rats [138]. Thus, mixing of tissue from 
different ages would make accurate comparisons difficult 
More evidence for heterogeneity of glomerular and tubular basement membranes 
resulted from immunohistochemical studies. Using specific antibodies against EHS 
components, differences in labeling patterns in GBM and TBM were seen. The 
noncollagenous glycoproteins, laminin and fibronectin, were immunolocalized in mouse 
and rat kidneys [94,139]. It was revealed that laminin was uniformly distributed 
throughout TBM, mesangial matrix and Bowman's capsule in both mouse and rat 
kidneys. In the GBM, laminin was restricted to the lamina rara interna. However, 
contradictory results were reported for the distributions of fibronectin in mouse and rat 
kidneys. In the mouse, fibronectin was present only in mesangial matrix. In the rat, 
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fibronectin was abundant in the mesangial matrix, but it was also detected in the lamina 
rarae of the GBM, Bowman's capsule and to a lesser extent in the TBM. Thus, these 
results not only suggested heterogeneous compositions among basement membranes, but 
also between animal species. With this in mind it was of interest to compare the mouse 
and rat GBMs described separately in this dissertation to further explore this issue of 
basement membrane heterogeneity between species. 
Identical amounts of lyophilized mouse and rat GBM were used, and the extraction 
procedures and volumes were identical. In comparing the extraction procedures of the 
two GBMs, total protein measurements revealed that 30% of mouse and 50% of rat GBM 
were extracted. This suggested an incomplete solubilization of the GBMs. However, 
visually comparing the GBMs before and after the extractions, it was demonstrable that 
the majority of the pellets were extracted leaving a small insoluble pellet. Protein assays 
can be very accurate in measuring individual protein solutions provided the appropriate 
standards are used. However, these assays are clearly inadequate to precisely measure a 
complex mixture of proteins. Due to the large diversity of the macromolecular 
composition of the GBM, the protein standard, bovine serum albumin, cannot accurately 
represent these macromolecules. Unfortunately, there is no one protein that can do this. 
Therefore, results based solely on protein assays must be used with caution and should be 
used for relative measurements. 
Comparing electrophoretic protein profIles from the mouse (Fig. m.S) and rat (Figs. 
IV.7, IV.8, & IV.9) GBM extracts revealed an overall similarity with subtle differences. 
The guanidine extracts revealed numerous bands ranging from 400 kD down to the dye 
front (45 leD) in both animals. The extracts with DTf revealed fewer small molecular 
weight bands in mouse GBM compared to rat OBM. The significance of this is 
unknown. The SDS extracts from mouse and rat GBM revealed remarkable similarities: 
strong staining bands that migrated alongside the alpha chains of type IV collagen. 
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Immunoblotting revealed the presence of laminin and fibronectin exclusively in the 
guanidine and DIT extracts in both mouse and rat GBM. In the case of laminin, the B 
chains were detected in these extracts of mouse and rat OBM. However, the A chain was 
not detectable in either mouse or rat GBM. This absence of staining was believed to be 
due to undetectable amounts of A chain or that an undiscovered isofonn of laminin A 
chain was present in GBM. 
Quantitation of total extracted laminin revealed a large difference in the content 
between mouse and rat GBM: mouse GBM contained 2.6 times less laminin compared to 
rat OBM (1.8 J,1g vs 4.6 Ilg/mg, respectively). Quantitation of fibronectin revealed 
similar amounts in mouse and rat OBM, 8.2 J.1g vs 7.2 J,1g/mg, respectively. Mouse and 
rat OBMs appear to share similar compositions, but have significant differences in 
relative amounts. Thus, these differences suggest heterogeneity among the GBMs of 
these two rodents. 
More substantial evidence for macromolecular heterogeneity of glomerular and 
tubular basement membrane resulted from the discovery of isofonns of laminin, and type 
IV collagen. An isofonn of laminin demonstrated a heterogeneous distribution among 
renal basement membranes. The recently described S-laminin or laminin Bls was 
detected in rat, rabbit and human OBM, but not TBM [32,33,140]. Similarly, two 
isoforms of type N collagen were recently identified as described in chapter two. These j 
novel chains of type N collagen [a3(N) and a4(IV)] were localized only to the lamina 
densa and lamina rara extema of the GBM [33,141-143]. A greater distribution of the 
classical chains of type IV collagen has been shown. These classical chains of type IV 
collagen [al(N) and a2(IV)] were localized to the lamina rara interna (subendothelial 
aspect), mesangial matrix, and all tubular basement membranes in human kidneys [141-
143]. The recently described a5(IV) chain of type IV collagen was shown to be 
restricted to the OBM by immunostaining [144]. 
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While immunocytochemistry is the ideal technique for localization of specific 
basement membrane components, this technique does not permit determination of 
absolute concentrations of various components of basement membranes. The assessment 
of known as well as unknown components requires solubilization of the basement 
membrane. 
Mohan and Spiro [15], were the only investigators to report amounts of solubilized 
OBM components, but not for TBM. The results described in this dissertation are the 
only reported amounts for solubilized components of GBM and TBM from the same 
kidney. Using these tissues from the same kidneys and isolated under identical 
conditions, thus allowed for precise comparisons of the two basement membranes. 
Compositional heterogeneity was clearly demonstrated between mouse GBM and TBM 
as previously described (chapter three). Along with qualitative differences in 
electrophoretic protein profiles, the total amount of laminin measured in the GBM was 
half that of TBM. 
From the studies described above, it was apparent that glomerular and tubular 
basement membranes shared similar components; however, the amounts varied. On the 
basis of this heterogeneity in basement membrane composition, it was postulated that 
concentration differences in various components would result in heterogeneity of 
structure and function [10,145]. If this postulate was true, then the glomerular and 
tubular basement membranes should have different functions. Currently, this cannot be 
answered because the functional significance of the TBM has not been defmed. The 
major function of the GBM has been shown to be a highly selective permeable barrier; 
however, the understanding of the mechanisms of this barrier is in its infancy. Although, 
sulfated glycosaminoglycans have a role in the charge selectivity in GBM, the 
physiological relevance, if any, of other basement membrane components has yet to be 
determined. In other words, do individual constituents impart penneability properties to 
the GBM? It is more likely that this property of the GBM is due to the sum and not 
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necessarily the individual parts. Electron microscopy studies have revealed that the GBM 
is composed of a backbone of type IV collagen to which other components attach [7]. 
These cords fonn a highly compact three dimensional meshwork that presumably imparts 
the size and charge restrictive properties. This implies that the components are 
distributed throughout the GBM; however, immunohistochemistry studies have 
demonstrated that the components are not uniformly distributed [14]. On the basis of on 
this, perhaps the cords vary in macromolecular composition, resulting in a composite 
structure with distinct regions or local environments. Evidence for distinct regions in the 
GBM exists for heparan sulfate proteoglycan. This proteoglycan was localized to the 
lamina rara intern a in apposition to the lamina dens a [146]. In this position, it is likely 
that the sulfated glycosaminoglycans generate a negatively charged shield retarding 
filtration of macromolecules by both electrostatic repulsion and sterlc hindrance. 
B EFFECTS OF DIABETES ON GLOMERULAR BASEMENT MEMBRANE 
COMPOSITION. 
It is generally known that in diabetes mellitus and passive Heymann nephritis, 
damage to the glomerular barrier occurs and is accompanied by an increase in 
penneability to proteins the size of albumin and larger. While the pathogenesis of 
proteinuria has not been established, alterations in the charge as well as the size barrier of 
the glomerular basement membrane have been suggested [64,147]. Furthennore, changes 
in the macromolecular composition of glomerular basement membrane have been 
implicated in proteinuria in both diabetes and passive Heymann nephritis [13,95]. The 
macromolecular alterations in these two diseases will be discussed separately in the next 
two sections. 
Insulin-dependent diabetes mellitus is characterized by progressive GBM thickening 
and proteinuria in later stages. Alterations in type IV collagen have been implicated in 
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the progressive thickening of diabetic OBM. An increase in type N. collagen in diabetic 
kidneys was originally based on measuring amounts of hydroxylated amino acids, namely 
hydroxylysine and hydroxyproline [148]. Hydroxyproline is unique to collagens and type 
IV collagen contains a higher percentage of both hydroxylysine and hydroxyproline than 
any of the fibrillar collagens. Thus, measurements of these two hydroxylated amino acids 
can provide a relative index of type IV collagen content [68,69]. Even though the amount 
of these hydroxylated amino acids is greater in type IV collagen, the presence of fibrillar 
collagens containing lesser amounts of these amino acids would have a diluting effect, 
resulting in a decreased content of these amino acids. Thus, the method of tissue 
isolation and preparation becomes increasingly clear as to the importance of obtaining 
reproducible pure GBM samples. The results based on these hydroxylated amino acids 
have been disparate. 
In 1970, Beisswenger and Spiro [148] first demonstrated a significant increase in 
the amount of hydroxylysine content in human diabetic OBM. Later they added a 
significant increase in the amount of hydroxyproline to their results on human diabetic 
GBM [68]. Similarly, Klein et al [69] showed that human diabetic glomeruli were larger, 
heavier and contained a greater amount of hydroxyproline than nondiabetic glomeruli. 
In contras~ three separate investigations demonstrated no significant changes in the 
amounts of these hydroxylated amino acids in human diabetic glomeruli [70-72]. 
Although the data were not statistically significant, there was an increase over control in 
these three investigations. It was noted when reviewing the data from these 
investigations that in all cases the kidneys were from cadavers that had varying durations 
of diagnosed diabetes ranging from 1 to 31 years. Furthermore, only some of the patients 
exhibited non-insulin dependent diabetes mellitus. Because of this non-homogeneous 
tissue, the severity of diabetic states was quite different in these patients. Since diabetes 
mellitus is a slow progressive disease involving glomerulosclerosis ultimately leading to 
renal failure, it is not surprising that conflicting results were obtained in these studies. 
150 
In an attempt to explain the disparity in these results, some of the investigations 
mentioned above will be reviewed as follows. The investigations by Klein et al [69] 
attempted a time course study measuring the levels of hydroxyproline in human diabetic 
glomeruli. The time course covered ten patients with durations of diagnosed diabetes 
ranging from 1 to 31 years. Of the ten patients only three were of insulin-dependent 
diabetes, and the duration of diabetes in these three ranged from 13 to 31 years. They 
found that in the 1 to 6 year range of diabetes, glomeruli showed no change in amounts of 
hydroxyproline. From the 7 to 31 year duration of diabetes, glomeruli showed significant 
increases in hydroxyproline. Interestingly, the increases were fairly constant, 39±2.2% 
(mean + SEM), considering the extreme differences in duration of diabetes, type and 
severity of disease. Similarly, results reported by Beisswenger and Spiro [68] showed 
that the increased hydroxylysine content in diabetic glomeruli appeared to be fairly 
constant, 15.4±2.5% (mean + SEM), over 6 to 26 year durations of diabetes. 
The lack of statistically significant increases in hydroxylated amino acids reported in 
the conflicting studies could be explained on the basis of tissue isolation techniques. 
Crude preparations of glomeruli were isolated at best using only an initial tissue-
disruption sieving step as opposed to more refined sieving procedures used by Spiro and 
colleagues. Thus, the overall discrepancies in type IV collagen content of diabetic 
glomeruli may be a result of techniques of basement membrane preparation and using 
nonhomogeneous diabetic tissue, i.e., kidneys differing in" duration of diabetic state 
and/or type of diabetes. Basement membrane preparations may be contaminated with 
interstitial collagens, which contain the same bydroxylated amino acids, thus an estimate 
of type IV collagen content based on these modified amino acids can not be considered 
optimal. 
The generation of antibodies to type IV collagen led to immunohistochemical studies 
revealing alterations in the distribution of type IV collagen in diabetic kidneys. 
Antibodies to Cll(IV) and a2(IV) chains of type IV collagen revealed increased staining 
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in GBM [95,96,105,149,150] of rats with a duration of diabetes ranging from 7 to 12 
months. However, staining of mesangial matrix revealed conflicting results for these two 
alpha chains of type IV collagen; Desjardins et al [95] showed no change in mesangial 
staining at 12 months of streptozotocin diabetes while Abrass et al [107] demonstrated a 
three-fold increase in staining after 6 weeks of streptozotocin diabetes. 
In two separate studies, heterogeneous staining for type IV collagen during 
progressive stages of diabetes in humans was revealed [96,105]. It was shown that in 
patients with "mild to moderate" diabetes (nonnal renal function to urinary protein 
excretion < 300 mg prot/day; varying degrees of thickened basement membrane and 
mesangial expansion) showed increased staining for type IV collagen in GBM and 
mesangial matrix [96,105]. However, when they examined GBM and mesangial matrix 
in patients termed "severe" (renal insufficiency, urinary protein excretion> 2.5 g 
prot/day, severe glomerular sclerosis and mesangial expansion) there was a significant 
decrease in staining compared with control tissue [96,105]. 
All of these studies described thus far have reflected long-tenn effects of diabetes on 
glomeruli from both human and experimental animals. Typically, these studies used 
tissue whereby morphological (thickened GBM and expanded mesangial matrix) and 
functional (decreased renal function and measurable proteinuria) changes were clearly 
established. Very few studies have been performed looking at the acute effects of 
diabetes on type IV collagen .content in glomeruli. They are summarized as follows. 
Ayo et al [106] demonstrated that mesangial cells cultured one week in high glucose 
concentration synthesized and secreted greater amounts of type IV collagen compared to 
mesangial cells grown in normal glucose concentrations. Similarly, Haneda et al [151] 
showed a significant increase in amount of secreted type IV collagen from mesangial 
cells cultured in high glucose concentration for 4, 6, 8 and 12 days. In an acute study 
with spontaneously diabetic KKAy mice, Ledbetter et al [101] measured the mRNA 
levels of a1(IV) and a2(IV) chains of type IV collagen in the cortices at 1, 2, 4 and 6 
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months of diabetes. No differences in mRNA levels were detected at 1 and 2 months 
while a two-fold increase was detectable at 4 months and continued to increase four-fold 
by 6 months. Recently, Ihm et al [102] using isolated glomeruli from streptozotocin 
diabetic rats detected no changes in glomerular al(IV) mRNA levels at 1 week or 1 
month. Thus, acute studies with cultured mesangial cells revealed a rapid induction of 
type IV collagen synthesis and secretion, whereas, whole animal studies reflected a much 
slower induction of type IV collagen synthesis. In the acute assessment of GBM 
composition described in chapter four, neither time nor disease affected the measured 
amount of type IV collagen. Thus, collectively these data indicate a lack of change in the 
amount of type IV collagen during the onset of experimental diabetes, therefore 
suggesting a delayed induction of type IV collagen synthesis. 
To summarize this account of type IV collagen in diabetes, amino acid analyses 
revealed a significant increase, albeit small, in type IV collagen content. Results from 
immunostaining revealed more substantially an increased staining for type IV collagen in 
diabetic GBM. Finally, results from cultured mesangial cells and whole animals 
demonstrated increased synthesis of type IV collagen. Taken together, these results 
demonstrate conclusively an increased amount of type IV collagen in the glomerular 
matrix of dia~tic lddneys. The specificity of this summary lies not so much in the 
uniqueness of increased type IV collagen, but rather in the time frame in which the 
increases were detectable. Perhaps. alterations in the GBM composition may be divided 
into distinct and progressive stages. 
Alterations in other GBM macromolecules have been implicated in insulin 
dependent diabetes mellitus. The laminin content of the GBM has been examined in 
experimental and human diabetes; however, results are disparate. Initial studies on 
laminin content revealed an increased amount in diabetes. Rohrbach et al grew EHS 
tumors in nonnal and genetically diabetic mice [73]. After three weeks, tumors were 
harvested and laminin was quantitated using inhibitory ELISA. It was demonstrated that 
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the tumors grown in diabetic mice had almost twice the laminin cpntent compared to 
tumors grown in nondiabetic mice. The relevance of ~s result is inconclusive due to the 
biological difference between the mature GBM of the glomerulus and the basement 
membrane-like matrix of the implanted tumor. 
The generation of antibodies to EHS laminin led to immunohistochemical studies 
that revealed alterations in the staining of laminin in diabetic kidneys. Falk et al 
examined the staining intensity of laminin in the GBM and mesangial matrix in two 
different stages of human diabetes [96]. In both GBM and mesangium, significant 
increases in laminin content were detected in early stages (patients presented with 
proteinuria, <300 mg/Day, varying degrees of GBM thickening and mesangial expansion) 
while significant decreases in laminin content were observed in severe stages (patients 
presented with proteinuria, >2.5g/day, thickened GBM, glomerulosclerosis and severe 
mesangial expansion). Similarly, Nerlich et al demonstrated with antibodies to laminin 
that significant increases in laminin staining were detected in early stages of diffuse 
glomerulosclerosis in diabetic kidneys and subsequent decreases in laminin staining in 
the late severe stages of nodular glomerulosclerosis [105]. 
U sing a radioimmunoassay, Shimomura and Spiro quantitated the amount of laminin 
in the GBM of diabetic kidneys taken at autopsy [12]. It was demonstrated that a 40% 
decrease in laminin was measured in diabetic kidneys compared with normal, 0.85 J,1g/mg 
GBM and 1.4 J.1g/mg GBM, respectively. Thus, these results taken with the 
immunohistochemistry data indicate that changes in laminin content may be divided into 
distinct stages during the progression of diabetes mellitus as was apparent for type IV 
collagen. 
An increased amount of laminin content in the early stages reflected either an 
increased synthesis of laminin mRNA and translation or decreased degradation and 
removal from the GBM. Ledbetter et al [101] measured the levels of laminin Bl chain 
mRNA in cortex from genetically diabetic mice after 1, 2, 3, and 5 months. They showed 
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no change in the mRNA levels during the acute stages of diabetes, even with evident 
proteinuria at one month. Giambrone and Brownlee [74] measured the levels of laminin 
B 1 chain mRNA in whole kidneys from streptozotocin diabetic rats after seven and ten 
months of disease. A three-fold increase in the level of laminin B 1 chain mRNA was 
demonstrable in these diabetic kidneys. It is difficult to extrapolate these mRNA results 
to the cells of the glomerulus. Unfortunately, no studies have measured the mRNA levels 
for laminin in isolated glomeruli. However, mRNA levels have been measured in 
cultured mesangial cells grown in high glucose concentrations after one week [106]. It 
was demonstrated that a 40 - 50 % increase in mRNA levels for laminin occurred after 
one week; furthermore, a 50 - 60 % increase in the amount of laminin was measured 
after one month in these cultured mesangial cells. 
In the acute assessment of GBM composition described in chapter four, laminin was 
significantly increased at day five and continued to increase through three months. Thus, 
collectively these data indicate an increased synthesis and amount of laminin during the 
onset of diabetes followed by a decrease in amount during the latter severe stages of the 
disease. 
Immunohistochemical studies of fibronectin revealed significant increases in 
staining during the early and moderate stages of human diabetes with subsequent 
decreases in the latter severe stages of the disease [96,105]. In these two 
immunohistochemical studies, the increased fibronectin staining was more pronounced in 
the mesangial matrix as compared to the GBM. Similarly, Abrass et al [107] 
demonstrated a significant increase in fibronectin staining in mesangial matrix in 
streptozotocin diabetic rats after six weeks. 
The effects of high glucose concentration on fibronectin synthesis in mesangial 
cells were examined. Cultured mesangial cells were grown one [106] and two weeks 
[152] in high glucose concentrations. It was demonstrated that both the amounts of 
fibronectin and mRNA levels were significantly increased in these cultured cells. 
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In the acute assessment ofGBM composition described in chapt~r four, quantitation 
of fibronectin revealed a significant increase at two months and persisted through three 
months. Shimomura and Spiro quantitated the amount of fibronectin from severely 
diabetic kidneys taken from autopsy and showed that there was no change in the amount 
of fibronectin in the latter severe stages of diabetes (diabetic, 2.9 J.lg/mg vs non diabetic, 
2.2 J.lg/mg GBM) [12]. 
Collectively these results for fibronectin indicated increased synthesis of fibronectin 
during the onset of diabetes with subsequent decreased amounts during the latter severe 
stages of the disease. Thus, suggesting a similarly altered differential expression during 
the progression of diabetes as was observed for laminin. 
Examination of entactin in diabetic kidneys was, until now, limited to 
immunostaining. Immunohistochemical studies revealed in early stages of diabetes 
prominent entactin staining in mesangium where mesangial expansion was present [108]. 
This mesangial staining disappeared with progression of the disease; however, thickened 
GBM showed an increased entactin staining. Amounts of entactin have not been 
measured in diabetic GBM. In the acute assessment ofGBM composition described in 
chapter four, quantitation of entactin revealed no effects of disease or time. Thus, in 
conjunction with immunohistochemical studies, entactin does not appear to be altered 
during acute stages, but may be affected with progression of diabetes. 
In the studies described thus far for type IV collagen, laminin, fibronectin and 
entactin, it was never precisely determined when alterations in these components 
occurred with reference to proteinuria. To determine if alterations in these 
macromolecules may be involved in the pathogenesis of diabetes or if alterations are a 
consequence of increased filtration, it is necessary to establish the differential alterations 
of these components during induction of the disease. 
The results in chapter four revealed that proteinuria in the streptozotocin diabetic 
rats was evident by day 28 and persisted through day 84. No changes in the amounts of 
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type IV collagen or entactin were measured in these diabetic rats; however, significant 
increases in both laminin and fibronectin were detected on days 5 and 56, respectively. 
The increase in laminin content over control preceded the onset of proteinuria, yet a more 
profound increase in laminin content occurred between days 28 and 56 at the time 
immediately after the onset of proteinuria. These differential increases in laminin content 
suggested that diabetes resulted in an initial increase that was subsequently exacerbated 
by the presence of proteinuria. 
The increase in fibronectin content over control was not apparent until after 
proteinuria had begun. However, this increase was profound and occurred, like laminin, 
during the interval immediately following the onset of proteinuria. Whether 
hyperglycemia had direct effects on laminin and fibronectin synthesis or that the 
increases were compensatory to restore normal fIltration are unknown. 
Recent studies have suggested an important role for the nonenzymatic glycation of 
various glomerular basement membrane proteins in contributing to the altered structure 
and function of the GBM in diabetes [153]. The metabolic consequence of 
hyperglycemia could be an important contributory feature to tissue damage in diabetes. 
Nonenzymatic glycation refers to the condensation reaction between glucose and free 
amino acids at the amino terminus of lysine residues of proteins [154]. GBM proteins 
such as type IV collagen are rich in lysine and hydroxylysine, have a long tissue half-life, 
and are continuously exposed to ambient levels of glucose in the blood [155]. Studies 
now demonstrate that there is a two- to three-fold increase in the level of glycation of 
collagens from tissues of diabetic subjects or animals compared to controls [155]. 
The effects of these glycations have included resistance to collagenase digestion 
and interference with normal cross-link fonnation [153], and changes in various physical 
properties of the molecules such as thennal stability and tensile strength [156]. Finally, 
the nonenzymatic glycation of noncollagenous GBM proteins that act as adhesion 
molecules, such as laminin [157], fibronectin [158], and heparan sulfate proteoglycan 
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[159], and thereby influence assembly and electrical charge of the basement membrane, 
may also have important functional consequences [160]. Loss of charge may ultimately 
contribute to proteinuria. 
Kanwar showed that a reduction in one of the anionic constituents of GBM 
(heparan sulfate proteoglycan), resulted in altered charge-permselectivity of the GBM 
with subsequent proteinuria [65]. Thus, the physiological relevance of the anionic charge 
barrier with the normal filtration properties of the GBM was demonstrated. However, it 
was not known to what extent a reduction in total heparan sulfate proteoglycan or 
alterations in individual heparan sulfate chains had on proteinuria in diabetes. 
Metabolic studies measuring the incorporation of 35S-sulfate in streptozotocin 
diabetic rats demonstrated a significant decrease in total glomerular glycosaminoglycans 
after 17 days of diabetes [161-163]. Studies were extended to include measurements of 
heparan sulfate in diabetic rats and humans [76,77]. These studies demonstrated 
significant reductions in heparan sulfate content of diabetic GBM. Further analyses 
revealed that, along with decreased levels of the glycosaminoglycan, alterations in the 
type of heparan sulfate were present in diabetic GBM. It was shown that heparan sulfate 
isolated from GBM of streptozotocin diabetic rats contained a reduced sulfation state 
resulting in an overall loss of effective charge [164,165]. 
Immunohistochemical studies of heparan sulfate proteoglycan revealed significant 
decreases in GBM staining during the early and moderate stages of human diabetes that 
persisted throughout the latter severe stages of the disease [105,166]. Quantitation of 
heparan sulfate proteoglycan in the GBM of diabetic kidneys taken at autopsy revealed a 
70% reduction in this proteoglycan, 1.9 Jlg/mg compared to control, 6.4 Jlg/mg GBM 
[12]. 
lbe effects of high glucose concentration on beparan sulfate proteoglycan synthesis 
in mesangial cells have been examined [167]. Cultured mesangial cells were grown 48 
hours in high glucose concentrations and the beparan sulfate proteoglycan content was 
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reduced by 53% as compared to control cells. The physiologica~ relevance of this 
decreased synthesis of heparan sulfate proteoglycan by mesangial cells is difficult to 
interpret as these cells make only 15 % of the total heparan sulfate proteoglycan present 
in the glomerulus [47]. In an acute study with spontaneously diabetic KKAy mice, 
Ledbetter et al [101] measured the mRNA levels of heparan sulfate proteoglycan in the 
cortices at 1, 2, 4 and 6 months of diabetes. No differences in mRNA levels were 
detected; however, these results can not be extrapolated to the cells of the glomerulus 
because of the contaminating mRNA from other cells of the cortex. 
The results thus far demonstrate that the contents of total glycosaminoglycans, 
heparan sulfate chains and heparan sulfate proteoglycans are all diminished in the early 
stages of experimental and human diabetes. Additionally, perturbations in the processing 
of heparan sulfate chains resulting in decreased sulfation were observed in diabetes. 
Thus, these studies provide evidence to support a strong relationship between proteinuria 
and reduced anionic charge content imparted by heparan sulfate proteoglycan. 
In the acute assessment of GBM anionic charge content described in chapter four, a 
significant reduction in negative charge content coincided with proteinuria in the diabetic 
rats. The alcian blue staining is only an indirect measurement of loss of heparan sulfate 
proteoglycan in the diabetic GBM. Other investigations have revealed similar reductions 
in anionic charge content in diabetic GBM using cationic probes. Examination of the 
diabetic rat and human GBM at the electron microscope level revealed marked loss of 
ruthenium red staining [168-170]. It would be interesting if the anionic sites of GBM 
were decreased locally in diabetes. In the electron microscopy studies of control GBM, 
staining with the cationic probes was localized to the lamina rarae. However, staining in 
diabetic GBM was attenuated with patches of no staining in the lamina rarae [168]. Thus, 
these results suggest that a marginal loss of anionic charge content could result in altered 
penneability. See figures VI. 1 and VL2 for possible models of GBM during nonna! and 
diabetic conditions. 
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In summary, the thickening of the glomerular basement membrane and the 
increased accumulation of mesangial matrix is a consequence of the metabolic 
abnormalities in diabetes and reflects a disturbance in the state of function. Presumably, 
the biochemical nature of the glomerular ftIter is not maintained. Alterations could occur, 
at the genome level involving changes in mRNA levels, at the posttranslational level 
involving perturbations in glycosylation, sulfation or hydroxylation steps that could alter 
function or assembly of components in the GBM, or at the turnover level involving 
changes in enzymes that degrade GBM. The increased blood glucose levels encountered 
in diabetes must in some way lead to changes in renal function. Evidence suggests that 
glucose has a direct effect to promote collagen biosynthesis by stimulating collagen gene 
expression, thus raising the possibility that the actions of diabetes to produce end stage 
renal failure could be in part due to direct effects of glucose on the cells of the glomerulus 
synthesizing glomerular matrix. One likely mediator of these effects could be 
nonenzymatic glycation of various GBM proteins that alters their structure and function 
and prevents normal degradation of collagen. 
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C EFFECTS OF EXPERIMENT AL GLOMERULONEPHRITIS ON 
GLOMERULAR BASEMENT MEMBRANE COMPOSITION. 
Human membranous glomerulonephritis is characterized by severe proteinuria 
[171]. Early stages of the disease display heavy proteinuria, subepithelial immune 
deposits and effacement and fusion of the glomerular epithelial cells. Later stages 
display expansion and remodeling of the glomerular baseme~t membrane. These 
morphological changes are accompanied by persistent and severe proteinuria. 
Passive Heymann nephritis (pHN) is an animal model that closely resembles human 
membranous glomerulonephritis [13]. PHN is immunologically induced by admin-
istration of a single injection of anti-Fx1A antibody. This antibody, generated in sheep, is 
directed against rat tubular brush border and cross-reacts with an antigen on the surface 
of glomerular epithelial cells [79]. As a result, anti-FxlA antibodies bind to an intrinsic 
glomerular epithelial cell antigen and formation of subepithelial immune deposits occurs 
[13]. These immune deposits activate the complement system leading to proteinuria five 
days after injection of antibody. Proteinuria is followed by structural alteration and 
thickening of the GBM around the subepithelial immune deposits. It has been suggested 
that alterations of the macromolecular composition of the GBM might change its size- or 
charge-selective properties, thus playing a role in progressive proteinuria [172]. 
Immunohistochemical studies on biopsy tissue of patients with membranous 
glomerulonephritis have characterized the distribution of classical and novel chains of 
type IV collagen, laminin B2 chain, fibronectin, and entactin/nidogen in the GBM [83]. 
No differences in staining for the components were observed at stage I of the disease in 
which small immune complexes were detected without morphological changes to the 
GBM. By stage II, immune deposits had increased in size and first signs of GBM 
invaginating (spikes) these deposits were apparent, and an alteration in immunostaining 
was detected. The subepithelial spikes or projections and areas of thickened GBM 
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demonstrated significant staining for the novel chains [a3(IV) & a4(IV)] of type IV 
collagen~ laminin B2 chain and entactin/nidogen~ but no changes in the staining of 
classical chains [al(IV) & a2(N)] of type IV collagen or fibronectin. In stage m, the 
immune deposits were completely embedded in the GBM, which displayed marked 
thickening. Staining of the aforementioned components continued to increase with an 
increase in staining for the classical collagen chains and fibronectin now demonstrable. 
In summary, after deposition of immune deposits in the subepithelial side of the GBM, 
this membrane sent projections up and around the deposits. These projections consisted 
predominantly of novel chains of type IV collagen, laminin and entactin/nidogen that 
eventually enveloped the immune deposits. This resulted in a thickened subepithelial 
GBM at which time a subsequent increase in classical chains of type IV collagen and 
fibronectin in the subendothelial side were detected. Ultimately, this process resulted in 
an overall thickened GBM. The immunostaining studies demonstrated alterations in the 
GBM macromolecular composition in PHN. However, these alterations might only 
reflect s~ctural rearrangements of the GBM as the subepithelial immune deposits grow 
and not actual alterations in the synthesis of the macromolecules. 
. Results from immunohistochemical studies are limited to information on relative 
amounts and distributions of components in GBM. These studies can not yield data on 
the synthesis and/or absolute amounts of components in the GBM. In an acute study of 
PHN, the synthetic rates of type IV collagen, laminin and fibronectin were assessed [80]. 
The mRNA levels of these macromolecules were quantitated. in isolated glomeruli and 
found not to be different from control values at one week, three weeks, or three months 
even in the presence of thickened GBM. 
Studies of quantitation of type IV collagen, laminin, fibronectin and 
entactin/nidogen in GBM from rats with PHN are scarce. The results outlined in chapter 
four demonstrated severe proteinuria at day five with no measurable changes in type IV 
collagen, laminin~ fibronectin, and entactin content in the GBM of PHN rats for any time 
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point in the study. Similarly, Floege et al [109] revealed no. changes in these 
macromolecules.. It was shown that rats displayed marked proteinuria by day five, with 
no significant alterations in glomerular morphology or OBM expansion seen during the 
fifteen day period. Immunostaining of renal biopsy for type IV collagen, laminin, s-
laminin, fibronectin and entactin were unchanged at all time points compared to controls. 
At days ten and fIfteen, there was a minor decrease in immunostaining for heparan sulfate 
proteoglycan in PHN OBM compared to control. Gene expressions .of type IV collagen, 
laminin B2 chain, and s-laminin were examined and the mRNA levels for these 
components were unchanged during the fifteen day study. 
The study by Floege et al [109] also examined the macromolecular composition and 
gene expression of the GBM components during the acute stages of active Heymann 
nephritis. This model of human membranous glomerulonephritis is induced by 
immunizing rats with the FxlA antigen .. As compared to the passive form, the active 
fonn of Heymann nephritis has a slower induction with significant proteinuria occurring 
by three months. Thus, the time frames for acute studies in these two fonus of Heymann 
nephritis are very differen~ several weeks versus several months. In contrast to their 
results on PHN GBM, rats with active Heymann nephritis showed increased 
immunostaining for laminin, s-laminin, fi bronec tin, entactin and heparan sulfate 
proteoglycan at three months onward.. The mRNA levels for laminin 82 chain and S-
laminin were significantly increased by three months. It was concluded that proteinuria 
occurred before the increased synthesis of GBM macromolecules. Thus, the mechanisms 
that lead to thickened OBM are probably different from the complement-induced 
proteinuria. 
Alterations in the charge selective barrier have been suggested as the cause of 
proteinuria in membranous glomerulonephritis [84]. Groggel et al used an experimental 
model of membranous glomerulonephritis in rabbits and found loss of charge selectivity 
in the GBM resulting in proteinuria [84]. Although the total amount of 
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glycosaminoglycans was unaltered, the sulfate incorporation into heparan sulfate was 
decreased. Thus, the loss of charge selectivity correlated with a change in the structure of 
heparan sulfate after twenty-four hours. The importance of an anionic barrier for the 
inhibition of protein leakage from the glomerulus was also demonstrated using a 
monoclonal antibody against a GBM heparan sulfate proteoglycan [147]. Injection of 
this monoclonal antibody resulted in a dose-dependent, transient, and selective 
proteinuria that was maximal immediately after injection. Thus, the importance of 
maintaining the charge barrier for nonnal filtration is abundantly clear. However, the 
relevance of these studies to the induction of proteinuria in membranous 
glomerulonephritis is unclear as these studies probably do not involve the complement 
cascade. 
Recent studies on the intrinsic glomerular epithelial cell antigen with which the 
FxlA antibody cross reacts revealed the involvement of integrin receptors. The ability 
for a cell to interact with the basement membrane or neighboring cells requires the use of 
cell surface receptors. Although specific cell surface receptors for collagens, laminin, 
and heparan sulfate proteoglycans have been identified, the best described receptors are 
of the integrin family, which are transmembrane proteins that integrate the cytoskeleton 
with the basement membrane [110]. Integrins are heterodimeric molecules, consisting of 
noncovalently associated a and 13 subunits. Both subunits are transmembrane proteins, 
consisting of large amino;..tenninal extracellular domains, single hydrophobic membrane-
spanning sequences, and short carboxy-tenninal cytoplasmic domains [42]. Adler and 
Chen [79] demonstrated that the FxlA antibody recognizes the· a3Pl integrin, 
specifically the 131 subunit. In studies with cultured rat glomerular epithelial cells, anti-
FxlA antibody inhibited growth, spreading, and adhesion to type IV collagen, laminin 
and fibronectin. Similar results were produced when using anti-PI antibody. 
It has been postulated that antibodies to glomerular epithelial cell antigens 
interfered with the normal cell-GBM interaction resulting in epithelial cell effacement 
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and retraction from the GBM [110]. Subsequent1y~ the altered interaction of the epithelial 
cell and GBM in conjunction with the complement system resulted in proteinuria. 
In summary, the pathogenesis of PHN, in which severe proteinuria and progressive 
thickening of the GBM are characteristic, is unknown. Overt proteinuria occurred 
without alterations in type IV collagen, laminin, fibronectin, entactin and anionic charge 
content. The lack of change in the GBM macromolecular composition suggested that 
these components were not involved in the pathogenesis of proteinuria in PHN. The 
mechanism of proteinuria remains elusive. However, recent evidence suggests that the 
interference of DOnnal glomerular epithelial cell attachment with the GBM is involved in 
the pathogenesis of proteinuria. See figure VI.3 for a possible model of GBM during 
PHN conditions. 
In conclusion, basement membrane heterogeneity was examined aDd results 
presented here demonstrate that mouse glomerular and tubular basement membrane share 
similar compositions but differ with respect to specific amounts of some components. 
Similarly, macromolecular compositional heterogeneity was shown between animal 
species: Mouse and rat OBM share similar components but differ significantly in 
amounts. It is currently unknown which individual components impart permeability 
properties to the GBM; however, heparan sulfate proteoglycan has been shown to be 
involved in generating a charge barrier and thus, restricting the passage of negatively 
charged macromolecules. Perhaps laminin, with its high sialic acid content and entactin, 
with its sialic acid and sulfate groups, are involved in charge pennselectivity due to these 
negatively charged groups on each of these glycoproteins. If the absolute amount of 
individual components imparts the functional differences observed between various 
basement membranes, then it will be necessary to know the relative amounts of the 
macromolecules to determine the functional significance of individual components. 
Systems need to be designed that will enable measurements of the penneability properties 
of individual components. For example: sequential addition of individual GBM 
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components onto a support with protein permeability measurements made between 
additions. Clearly, much work is needed to understand the physiological relevance, if 
any, of each basement membrane macromolecule. 
The importance of understanding the GBM composition under normal conditions 
cannot be emphasized enough as alterations in composition have been demonstrated to be 
involved in various kidney diseases. The common denominators among various diseases 
afflicting the kidney are thickened GBM and proteinuria. The present study examined 
the macromolecular composition during the acute stages of experimental diabetes and 
PHN with emphasis on when compositional changes occurred, if any, in reference to the 
onset of proteinuria. It was shown conclusively that these two models of kidney disease 
are quite different. Diabetes affected the GBM macromolecular composition: a 
significant reduction in anionic charge content correlated with significant proteinuria and 
massive increases in both laminin and fibronectin that occurred in the period immediately 
following proteinuria. Therefore, it is likely that the decreased negative charge content 
resulted in proteinuria while the explosive increase in laminin and fibronectin were a 
compensatory result to ttpatch" the damaged glomerular barrier. Although overt 
proteinuria was evident after five days, passive Heymann nephritis had no effect on the 
GBM macromolecular composition: no changes in type IV collagen, laminin, 
fibronectin, entactin or anionic charge content were detected. Thus, the stimuli that lead 
to changes in GBM composition in diabetes are likely related to those which result in 
proteinuria; however, there appears to be no relationship between the GBM composition 
and overt proteinuria in PHN, or between the mechanisms for the induction of proteinuria 
in diabetes and PHN. 
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Figure VI. 1 A possible model for the macromolecular architecture of 
glomerular basement membrane constructed with the known molecules 
listed below. A type IV collagen lattice fonns the underlying structural 
support to which laminin, fibronectin, entactin/nidogen and heparan sulfate 
molecules attach. The GBM is attached and anchored to the opposing 
endothelial and epithelial cells through cell surface receptors (for example, 
integrins). It is possible that this anchorage provides the necessary shape that 
defines, in part, the penneability properties of the GBM. Under nonnal 
conditions, the GBM serves to retard the passage of serum proteins from 
leaving the capillary lumen yielding an ultrafutrate in the urinary space. 
Macromolecules are drawn to scale with respect to each other . 
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Figure VI.2 Proposed model of GBM during diabetic conditions. Diabetes is 
characterized by alterations in GBM and proteinuria. A decrease in anionic 
charge content is intimately associated with the appearance of proteinuria. The 
model shown here depicts a net loss of charge as a result of diminished amounts 
of heparan sulfate proteoglycan. Loss of negative charge may result in pathways 
opening up for plasma proteins to now traverse. The functional significance of 
increases in laminin and fibronectin is less clear. However, increased amount of 
these molecules may interfere with normal deposition and assembly of the GBM 
structure. Additionally, the hyperglycemia encountered results in nonenzymatic 
glycation of macromolecules. Interference and alterations in nonnal cross linking 
and packing of components might result in significant alterations in overall 









Figure VI.3 Proposed model of GBM during passive Heymann nephritis 
conditions.. Passive Heymann nephritis results in rapidly induced and severe 
proteinuria despite no alterations in GBM composition. The appearances of 
subepithelial immune deposits are undoubtedly a result of antibodies binding to an 
intrinsic cell surface antigen on glomerular epithelial cells. This antigen was 
recently discovered to be an integrin receptor. This receptor binds to type IV 
collagen, laminin, and fibronectinthus, anchoring the GBM to the epithelial and 
endothelial cells of the glomerulus. Thus, in this model of human membranous 
glomerulonephritis, antibodies interfere with the anchoring of the GBM to the 
epithelial cells. This loss of anchorage results in fusion and effacement of 
epithelial cells and in conjunction with distortion of GBM by the enlarging 
subepithelial immune deposits causes structural alterations in the glomerular 
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